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Abstract 
Skeletal Muscle Eukaryotic Elongation Factor 2 (eEF2) Response to Acute Resistance Exercise 
in Young and Old Men and Women:  Relationship to Muscle Glycogen Content and 5’-AMP-
Activated Protein Kinase (AMPK) Activity 
By:  Jennifer Lea Macesich 
July, 2010 
Director: Dr. Scott E. Gordon 
DEPARTMENT OF EXERCISE AND SPORTS SCIENCE 
 Sarcopenia is associated with an age-related decrease in skeletal muscle mass, which can 
result in decreases in strength and physical functioning in the older population.  Resistance 
training interventions are not completely effective in stimulating muscle protein synthesis in 
aged muscle and thus do not completely combat age-related atrophy.  Phosphorylation (and thus 
theoretically activation) of the energy-sensing molecule 5’-AMP-activated protein kinase 
(AMPK, known to inhibit the muscle protein synthesis pathway) has been shown to be elevated 
for up to three hours in response to a resistance training bout in the muscles of older, but not 
younger individuals.  Data in rats indicate that, in response to muscle contractions, elevated 
AMPK activity can accentuate the inhibitory phosphorylation (and thus deactivation) of its 
downstream intermediate, eukaryotic elongation factor 2 (eEF2, which normally stimulates 
protein translation and synthesis).  AMPK activity is inhibited by high muscle glycogen levels.  
Interestingly, older individuals exhibit a lower muscle glycogen content compared to younger 
individuals, which may account for the greater AMPK phosphorylation response to resistance 
exercise in older individuals.  The relationship between muscle glycogen content, AMPK 
activity, and eEF2 phosphorylation in response to an acute bout of resistance exercise has not yet 
 
 
been examined in young or old individuals.  We hypothesized that inhibitory eEF2 
phosphorylation would be higher in response to an acute resistance exercise bout in the skeletal 
muscles of older versus younger individuals.  We further hypothesized that this higher eEF2 
phosphorylation response would be related to a higher AMPK activation, and that higher AMPK 
activation would be related to lower glycogen content, in the skeletal muscles of older versus 
younger individuals.  Seven young (21.7 ± 0.8 yrs) and 10 old (67.0 ± 2.6 yrs) untrained but 
physically active men and women performed 3 sets of leg extensions at a 10-repetition maximum 
resistance until failure after an overnight fast.  Muscle biopsies were obtained from the vastus 
lateralis pre-exercise (PRE), immediately post exercise (0P), 1-hour post exercise (1P), and 2-
hours post exercise (2P).  Glycogen content was measured in muscle samples, as were the 
phosphorylations, by western blot, of AMPK (Thr172), acetyl-CoA carboxylase (ACC, a marker 
of in vivo AMPK activity) (Ser79), and eEF2 (Thr56).  Muscle glycogen content was 
significantly lower in the old vs. young subjects at the PRE time point and decreased in response 
to exercise in both age groups; however, glycogen content decreased to a greater degree in young 
subjects such that it was equal between young and old at all post-exercise timepoints.  As 
expected, AMPK phosphorylation was significantly increased in the old subjects immediately 
post exercise, but no such response was noted in the young.  However, no age-related differences 
were observed in AMPK activity as measured by ACC phosphorylation, which was significantly 
elevated at 0P and 1P in both age groups.   Similarly, the eEF2 phosphorylation response 
(elevated vs. PRE at 0P and decreased vs. PRE at 1P and 2P in both age groups) was also not 
affected by age.  Regardless of age, higher muscle glycogen content was associated with lower 
AMPK activity (as assessed by phospho-ACC content) at 0P and 1P, and this lower AMPK 
activity was associated with lower inhibitory phosphorylation of eEF2 at those same timepoints.  
 
 
These findings indicate the possibility that higher muscle glycogen content may result in lower 
AMPK activation and consequently lower inhibitory eEF2 phosphorylation in response to a 
resistance training session in the muscles of both younger and older individuals, thereby 
potentially enabling greater translation elongation, protein synthesis, and muscle growth 
regardless of age. 
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CHAPTER 1:  INTRODUCTION 
Sarcopenia 
 In the future of our country, the proportion of Americans to fall into the “aged” or “older” 
category is expected to increase significantly.  To compound this “baby boom” generation 
reaching older adulthood, the lifespan has also increased drastically (Mokdad et al., 2004).  
There is a strong connection between declines in physical function with advancing age, which is 
accelerated as age continues to increase (Beckett et al., 1996).  A decrease in physical function is 
of concern due to the resulting inability to perform usual activities of daily living (Beckett et al., 
1996).  A portion of this physical disability can be attributed to a reduction in skeletal muscle as 
associated with aging (Janssen, Heymsfield, Wang, & Ross, 2000) .  At about 45 years of age the 
decrease begins, this age-associated decline in muscle mass is known as sarcopenia (Janssen, 
Baumgartner, Ross, Rosenberg, & Roubenoff, 2004).  There is roughly a 30% decrease in 
muscular strength when comparing the second and seventh decades of life (Rogers & Evans, 
1993).  The decrease in muscle mass is mostly associated with atrophy of the type II fibers (Lee, 
Cheung, Qin, Tang, & Leung, 2006). 
It is estimated that approximately 45% of the elderly United States population can be 
categorized as having sarcopenia, which encompasses both men and women (Janssen, 
Baumgartner et al., 2004).  Sarcopenia is associated with an increase in disability which leads to 
increases in healthcare expenditures.  Approximately $18.5 billion, or 1.5% of the healthcare 
costs in the US in 2000, is due to sarcopenia.  Every individual suffering from sarcopenia does 
not necessarily experience a decrease in their functionality, but depending on the severity, the 
risk can range from 1.5 to 4.6 times higher than an individual without sarcopenia.  If sarcopenia 
could be eliminated approximately 85.6% and 26.0% of men and women, respectively, disability 
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cases could be prevented, helping to alleviate a portion of the economic burden from healthcare 
(Janssen, Shepard, Katzmarzyk, & Roubenoff, 2004).   
Resistance Training 
 Resistance training has been shown to improve muscular strength and potentially reverse 
or hinder the negative effects of sarcopenia (Marini et al., 2008; Rogers & Evans, 1993).   
Resistive exercises have proven to increase the muscular strength and volume in old individuals 
(Kryger & Andersen, 2007).  Older individuals who were exposed to persistent exercise training, 
possibly lifelong, have been reported to exhibit larger muscle sizes and mechanical performance 
(Aagaard, Magnusson, Larsson, Kjaer, & Krustrup, 2007).  However, others have found that 
older subjects exhibit a blunted hypertrophic response to progressive resistance training when 
compared to younger subjects who have underwent the same exercise regimen (Kosek, Kim, 
Petrella, Cross, & Bamman, 2006; Raue, Slivka, Minchev, & Trappe, 2009).  Several studies 
have also compared old and young rat muscles and have revealed that when introduced to an 
overload the old muscles hypertrophy to a lesser extent than that of the young (Thomson & 
Gordon, 2005).  There is a disparity in the ability of the muscle to hypertrophy based on fiber 
type.  It appears that slow twitch fibers (type I) can significantly enlarge, while fast twitch (type 
II) fibers sometimes show little to no improvement (Kosek et al., 2006; Thomson & Gordon, 
2005) 
Protein Synthesis 
 Protein synthesis is a process in which proteins are synthesized within the muscle by 
various intracellular processes. Exercise training can lead to an increase in the size of the muscle 
due to an increase in the contractile proteins in the muscle.  During the post exercise period, 
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protein synthesis will ideally outweigh the degradation of protein within the muscle and 
therefore result in an increase in the available proteins (Drummond, Miyazaki et al., 2008).  Age-
related losses are present between young and old subjects in expression of genes for the 
regulation of muscular protein synthesis at baseline levels (Drummond, Miyazaki et al., 2008).  
Similar differences can also be seen between age groups in response of protein synthesis itself to 
a single bout of leg extension exercise (Kumar et al., 2009; Sheffield-Moore et al., 2005).  It is 
possible that these critical differences in protein synthesis account for the lower skeletal muscle 
hypertrophy seen in older individuals with resistance training   
Signaling Pathways 
 The processes of protein synthesis are abundantly regulated by upstream signaling 
pathways.  Akt/mammalian target of rapamyacin (mTOR) is critical for protein translation, 
synthesis of new proteins and therefore muscle hypertrophy (Bodine et al., 2001).  An increase in 
effectiveness and ability for the process to proceed is promoted by mTOR and its control of 
activity of certain downstream intermediates, such as 70-kDa ribosomal protein S6kinase 
(p70S6k) and eukaryotic translation elongation factor 2 kinase (eEF2) (Kimball, Horetsky, & 
Jefferson, 1998).  The p70S6k protein stimulates the translation process of a variety of ribosomal 
proteins and elongation factors including the downstream activation of eEF2 (Terada et al., 
1994).  That is, p70s6K stimulates global translation by first specifically recruiting and 
translating 5’ tract of pyrimidine (5’TOP) mRNA, which encodes for specific proteins of the 
ribosomal machinery itself as well as for eEF2 (Ryazanov, Shestakova, & Natapov, 1988).  
Translation elongation is also augmented by p70s6K’s inhibition of eukaryotic elongation factor 
2 kinase (eEF2k), which, when active, would otherwise phosphorylate and deactivate eEF2 
(Ryazanov et al., 1988).  Signaling through these crucial components (mTOR, p70s6k, and 
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eEF2) displays an increase in activity when stimulated with an acute bout of contractile activity 
in young muscle (Bodine et al., 2001; Parkington, Siebert, LeBrasseur, & Fielding, 2003), but 
has been shown to be suppressed in aged fast-twitch muscle in response to overloading and/or 
resistance exercise (Kumar et al., 2009; Parkington, LeBrasseur, Siebert, & Fielding, 2004; 
Thomson & Gordon, 2006).  The inhibitory phosphorylation of eEF2 at Thr
56
 is higher in old rat 
skeletal muscle and tends to further increase under overload conditions (Thomson & Gordon, 
2006).  Correspondingly, the p70s6k and eEF2 signaling pathways are both inhibited after 
electrical stimulation in old rat skeletal muscle (Fick & Gordon, 2007).  Although one finding in 
humans indicated that the phosphorylation of eEF2 (Thr
56
) was not different between the young 
and old age groups after resistive exercise, that exercise was performed after the ingestion of an 
essential amino acid (EAA) and carbohydrate rich drink (Drummond, Dreyer et al., 2008).  
Theoretically, that EAA stimulus would bypass AMPK and enhance the responses of mTOR and 
its downstream effects such as p70s6k and eEF2 signaling (as well as protein synthesis).  Thus, 
the effect of resistance exercise in young and old subjects under normal (without an EAA 
stimulus) remains to be determined. 
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Figure 1.1. The mTOR signaling pathway.  Mammalian target of rapamyacin (mTOR) activates 70 
kDa ribosomal protein s6 kinase (p70s6k) which inhibits eukaryotic elongation factor 2 kinase (eEF2k) 
from deactivating eukaryotic translation elongation factor 2 (eEF2).  Thereby increasing elongation and 
recruitment and translation of 5’ tract of pyrimidine (5’ TOP) resulting in increased protein synthesis and 
muscle growth. 
 
AMPK 
 5’-Adenosine monophosphate-activated protein kinase (AMPK), in essence, is an energy 
sensing protein that responds based on the ratio of AMP/ATP (Winder & Hardie, 1999).  It is 
activated during instances of metabolic demand, such as resistive exercise, and stimulates the 
generation of ATP while impeding processes that are metabolically expensive, such as protein 
synthesis (Thomson & Gordon, 2005).  AMPK “turns off” protein synthesis by inhibiting the 
signaling to activate mTOR and thereby shutting down the downstream proteins from allowing 
translation elongation and the recruitment of 5’TOP, as reviewed (Gordon, Lake, Westerkamp, & 
Thomson, 2008).  In some tissues, AMPK may also bypass mTOR-p70s6k signaling to more 
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directly inhibit protein synthesis by stimulating eEF2k, which subsequently inhibits eEF2 
(Browne, Finn, & Proud, 2004). 
During a bout of exercise muscular ATP stores stay relatively constant, however; AMP 
levels can become elevated and therefore increase the ATP/AMP ratio (Hardie & Sakamoto, 
2006).  AMPK senses this shift in energy stores it reflexively initiates the synthesis of ATP, 
through energy saving processes such as glucose uptake and lipid catabolism (Hardie & 
Sakamoto, 2006).  In turn, AMPK phosphorylates (an activation mechanism) and activates 
intermediates that block mTOR activity in attempt to replenish ATP and conserve energy 
(Hardie & Sakamoto, 2006).  AMPK activation has a strongly negative correlation with 
overload-induced muscular hypertrophy (Thomson & Gordon, 2005), and a significantly higher 
activation in old (O) versus young (Y) participants after resistance exercise (Drummond, Dreyer 
et al., 2008).  This same effect of higher AMPK activation has also been seen in O rats as 
compared to Y when in overloaded fast twitch muscle (Thomson & Gordon, 2005).  Although, 
this likely occurs in an attempt to restore the energy imbalance of the AMP/ATP ratio typically 
observed in old skeletal muscle post exercise (Bastien & Sanchez, 1984), the result may also be 
an inhibition of the response of the mTOR pathway typically observed in young muscle.  In fact, 
the elevated AMPK phosphorylation observed in aged rat fast-twitch muscle during overload is 
associated with a diminished response of markers of mTOR activity (p70S6k and eukaryotic 
elongation factor binding protein-1) as well as eEF2 (Thomson et al. 2006).  An acute resistance 
training bout did elicit an increase in the phosphorylation of AMPK, (which is normally an 
inhibitor of mTOR, p70s6k, eEF2, and protein synthesis) in the muscles of elderly, but not young 
(Drummond, Dreyer et al., 2008).  Thus, AMPK is one potential mechanism inhibiting the 
protein synthesis and hypertrophy response to overload in old muscle.   
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Glycogen and Diet in the Elderly 
When comparing diet between young and old subjects, it has been shown that the elderly 
not only consume fewer calories, but also fewer carbohydrates (Lieberman, Wurtman, & 
Teicher, 1989).  Between the two groups, most of the snacks consumed are carbohydrate rich; 
however, the elderly are eating less snacks as compared to the young (Lieberman et al., 1989), 
which could account for some of the decrease in carbohydrate consumption.  In accordance with 
a reduction of consumed carbohydrates, the elderly have been shown to have lower muscle 
glycogen content, trained and untrained, when compared with young subjects (Cartee, 1994).  
Young subjects that are introduced to an exercise bout exhibit a decrease in available glycogen 
stores post exercise session (Harber et al., 2008).   
It is suggested that the degree of AMPK activation during exercise is in part regulated by 
the availability of fuel in the skeletal muscle (Wojtaszewski et al., 2003).  When comparing a 
rested muscle during low carbohydrate state, or glycogen depleted, with a carbohydrate-rich 
state, or high glycogen content, AMPK activity levels were seen to be elevated in times of low 
glycogen content (Wojtaszewski et al., 2003).  This suggests there is some connection between 
the AMPK phosphorylation and the amount of available muscle glycogen.  During exercise the 
glycogen depleted state exhibits an enhanced uptake of circulating fuels that could potentially be 
associated with the elevated AMPK activation (Wojtaszewski et al., 2003).   
Specific Aim 
Resistance training has been proven to elicit hypertrophy in older subjects, but to a lesser 
extent than young counterparts (Kosek et al., 2006; Raue et al., 2009).  In response to overload or 
resistance training, elderly humans and rats have shown to have a decreased skeletal muscle 
activation of mTOR and p70s6k (Kumar et al., 2009; Parkington et al., 2004; Parkington et al., 
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2003; Thomson & Gordon, 2006)  as well as a lower protein synthesis response compared to 
young muscle (Kumar et al., 2009).  The inhibitory phosphorylation of eEF2 is higher in older 
vs. younger rat skeletal muscle, and also tends to increase with overload only in old (Thomson & 
Gordon, 2006).  Another key finding was that p70s6k and eEF2 signaling are both inhibited in 
old versus young rat muscles after electrical stimulation (Fick & Gordon, 2007).  Another study 
in humans observed that the eEF2 phosphorylation response to resistance exercise did not differ 
between age groups when all subjects had ingested an essential amino acid (EAA) and 
carbohydrate drink prior to exercise (which would theoretically bypass AMPK and enhance the 
responses of mTOR and its downstream effects such as p70s6k and eEF2 signaling as well as 
protein synthesis) (Drummond, Dreyer et al., 2008).  The eEF2 response to acute resistance 
exercise has not been examined in younger vs. older humans under normal circumstances (i.e., in 
the absence of an EAA/carbohydrate drink).  Interestingly, the acute resistance training bout did 
elicit an increase in the phosphorylation of AMPK (normally an inhibitor of mTOR, p70s6k, 
eEF2, and protein synthesis in the absence of an EAA/carbohydrate drink) in the muscles of 
elderly, but not young, individuals in that study (Drummond, Dreyer et al., 2008).  Low levels of 
muscle glycogen have been shown to stimulate AMPK activity (Wojtaszewski, Jorgensen, 
Hellsten, Hardie, & Richter, 2002).  Thus, the lower muscle glycogen content (Cartee, 1994) 
with age could explain the increased muscle AMPK phosphorylation and activity with age 
observed at rest and in response to overloading/resistance exercise (Thomson 2005, Drummond 
2008) that may subsequently lead to the decrease in muscle mass and/or diminished anabolic 
response to resistance exercise commonly seen in aged muscle.  Therefore, the aim of this study 
was to examine the eEF2 phosphorylation response to resistance exercise and its relation to 
muscle glycogen content and AMPK activation in old versus young subjects.  We hypothesized 
 
 
9 
 
that inhibitory eEF2 Thr56 phosphorylation would be higher in response to acute resistance 
exercise in the skeletal muscles of older versus younger individuals.  We further hypothesized 
that this higher eEF2 phosphorylation response would be related to higher AMPK activation, and 
that higher AMPK activation would be related to lower muscle glycogen content, in the skeletal 
muscles of older versus younger individuals.    
 
 
 
 
CHAPTER II: REVIEW OF LITERATURE 
Sarcopenia 
 As individuals age they tend to experience a decrease in their physical ability which tends 
to accelerate with advancing age (Beckett et al., 1996).  The population of Americans 
categorized as older adults is continuously increasing, so this burden of disability is becoming a 
public health concern (Janssen, Shepard et al., 2004).  The cause of the physical impairments can 
be attributed to several different rationales; most specific to this study is sarcopenia.  Sarcopenia 
is the wasting away of skeletal muscle associated with advancing age (Gordon et al., 2008).  
After the age of 45 muscle begins to atrophy and progressively worsens with age (Hughes, 
Frontera, Roubenoff, Evans, & Singh, 2002).  Concurrently with decreasing muscle mass, as 
individuals age they also tend to lose muscular strength (Rooyackers, Balagopal, & Nair, 1997).  
The trend has shown that the prevalence of sarcopenia increases from the third to the sixth 
decade of life, indicating increasing cases of sarcopenia with increasing age (Janssen, 
Heymsfield, & Ross, 2002).  The skeletal muscle tends to decrease not only in size but also in 
the number of fibers (Welle, 2002) and is mostly associated with the atrophy of the type II, fast 
twitch fibers (Lee et al., 2006).   
 Sarcopenia is directly related to an decrease in functional ability, (Janssen et al., 2002), 
and those suffering from the disease report a decreased quality of life when compared to non-
sarcopenic counterparts (Janssen, Shepard et al., 2004).  With 45% of the elderly population 
being to some degree sarcopenic, and therefore potentially losing physical ability, it puts a strain  
on the healthcare industry, financially speaking (Janssen, Baumgartner et al., 2004).  
Approximately $18.5 billion dollars alone can be attributed to sarcopenia related costs (Janssen, 
Shepard et al., 2004).  That is a significant amount of money going towards a very preventable 
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disease.  By exercise alone, which will be discussed farther in later sections, a person could 
spend roughly $600 per month on gym-based exercise and exercise counseling in an exercise 
facility in attempt to combat this age related process.  On the other hand, the same study revealed 
a person can expect to spend approximately $900 a month in costs due to sarcopenia (Sevick et 
al., 2000).  This financial standing alone indicates how serious of a problem sarcopenia is, and it 
will only worsen as the amount of Americans over 65 increases.  To date, sarcopenia accounts 
for a similar portion of healthcare funding as osteoporosis, however it has yet to see a public 
health campaign aimed at reducing the prevalence of it (Janssen, Shepard et al., 2004).  
 Several lifestyle choices can lead an individual in this down spiraling course, leading to 
muscle mass decline and disability.  First and foremost is the lack of physical activity.  It has 
been shown that older persons engaged in higher levels of physical activity have a slower rate of 
decline in motor performance (Buchman, Boyle, Wilson, Bienias, & Bennett, 2007).  Another 
common trend among elderly is a decrease in the amount of calories consumed (Janssen, 
Shepard et al., 2004).  Not only do they consume fewer calories per meal, but they also are 
consuming less protein, (Janssen, Shepard et al., 2004) as well as less carbohydrates(Lieberman 
et al., 1989).  Sarcopenia can also have an effect on various diseases, including diabetes, 
osteoporosis and obesity (Janssen, Shepard et al., 2004).  With this growing problem it is of the 
utmost concern to prevent this epidemic from advancing any farther than it already has.  Not 
only does it put a strain on our financial system, but it also decreases quality of life in the older 
population (Janssen, Shepard et al., 2004).   One of the best known interventions is resistance 
training, which causes the muscle to hypertrophy, a quick response to training (Janssen, Shepard 
et al., 2004).  While resistance training can help combat the decrease in muscle, it appears that 
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hypertrophy and strength gains are substantially reduced in old versus young subjects (Kosek et 
al., 2006; Trappe et al., 2003). 
Resistance Training  
 One approach commonly utilized to delay the progression of sarcopenia and encourage 
muscular growth is resistance training (Marini et al., 2008).  Frail individuals can see an 
advantageous increase in fiber size as well as strength when taken through a chronic resistance 
training routine (Kryger & Andersen, 2007).  Individuals who have continuously exercised 
throughout their lifespan tend to have larger muscle sizes and muscular performance (Aagaard et 
al., 2007).  For older individuals experiencing the decline in muscle mass, resistance training can 
assuage this process (Thompson, 1994).  The age related protein decreases are only partially 
reversed with resistance exercise, it does not entirely reverse the process of degeneration 
(Balagopal, Schimke, Ades, Adey, & Nair, 2001).  While older individuals can experience gains 
in their muscular strength, it tends to be a blunted response when compared to the gains a 
younger individual is able to achieve (Kosek et al., 2006).  This same trend can be seen in the 
hypertrophic response in aged versus young rats when looking at fast twitch fibers (Thomson & 
Gordon, 2005).  When comparing the genders and their abilities to increase muscular strength 
and hypertropic response women tended to have smaller increases than men (Bamman et al., 
2003).  There is also a discrepancy in the enlargement of the type of muscle fiber and its 
response to exercise.  The type II, or fast twitch fibers are the most susceptible to atrophy with 
age (Hortobagyi et al., 1995; Thompson, 1994), and are also the fiber type that shows no 
significant size improvements with resistance training (Frontera, Meredith, O'Reilly, Knuttgen, 
& Evans, 1988; Trappe et al., 2001),  this decreased amount of hypertrophy is also seen in fast-
twitch muscles of aged rats (Haddad & Adams, 2006; Thomson & Gordon, 2005). 
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Protein Synthesis 
 Protein synthesis is the process involving the translation of mRNA to create proteins 
from various amino acids within the muscle.  This process consists of three main steps, initiation, 
elongation, and termination.  The rate in which these processes occur is in part liable for the 
either hypertrophy of atrophy of the skeletal muscle.  In order for the muscle to grow the rate at 
which protein synthesis must exceed the rate at which protein degradation occurs (Phillips, 
Tipton, Aarsland, Wolf, & Wolfe, 1997).  Post resistance exercise, the rate of protein synthesis is 
shown to surpass that of breakdown and therefore result in an increase in overall protein mass 
availability (Phillips et al., 1997).  The normal response to a bout of resistance exercise, as seen 
in young individuals, is an increase in the rate of protein synthesis (Phillips et al., 1997).  This 
muscle protein synthesis response to a bout of resistance exercise is comparatively lower than 
that of young human subjects (Drummond, Dreyer et al., 2008; Kumar et al., 2009).  These same 
findings of lower rates of muscular protein synthesis are also found in the muscles of aged versus 
young rats when introduced to weight lifting exercise (Tamaki et al., 2000).  This could 
potentially explain why when an old muscle is introduced to an overload they are not capable of 
producing a hypertrophic response similar to that of young muscles (Thomson & Gordon, 2005).  
It has been shown that even at rest elderly individuals exhibit lower levels of skeletal protein 
synthesis (Yarasheski, Zachwieja, & Bier, 1993).  The atrophy, and lack of hypertrophy, as seen 
after a bout of resistive exercise is more inclined to strike type II fibers (Lee et al., 2006).  This 
noteworthy difference in the degree of protein synthesis in the muscle of varying cohorts can 
potentially explain the age-related atrophy of type II fibers.  
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mRNA Translation into Protein 
 Protein synthesis is initiated by either an increase in the available amino acids or by 
resistance exercise (Kimball, Farrell, & Jefferson, 2002).  The process begins in part because of 
the stimulation of mRNA translation (Kimball et al., 2002).  Protein synthesis is partially 
regulated by the initiation and elongation factors that are responsible for the rate of mRNA 
translation (Bodine et al., 2001).  The first stage of translational initiation the met-tRNAi binds to 
a 40S ribosomal subunit to form a tertiary complex, which includes eukaryotic initiation factor 2 
eIF2, GTP and met-tRNA (Kimball et al., 2002).  This allows the initiation factors to form a 43S 
preinitiation subcomplex (Kubica, Kimball, Jefferson, & Farrell, 2004).  This complex is 
responsible for scanning the mRNA strand until it arrives at the start codon, and once it reaches 
this location an 80S complex is formed, prepared for translation elongation (Kimball et al., 
2002).  
 Translation is based on the pairing of a codon on the mRNA and the anticodon on the 
tRNA caring the amino acid to form a polypeptide chain (Frank, Gao, Sengupta, Gao, & Taylor, 
2007).  The elongation cycle is a three step process that is consistently repeated which is 
catalyzed by a ribosome and two GTPases (Frank et al., 2007).  Eukaryotic elongation factor 2 
(eEF2) is responsible for directing the tRNAs into the exit site for removal (Browne & Proud, 
2002).  Translation termination is responsible for the release of the newly created polypeptide 
chain and its removal from the ribosome (Bolster, Crozier, Kimball, & Jefferson, 2002).  
Protein Translation via mTOR Signaling 
 Protein synthesis is vastly dependent upon upstream cellular signaling pathways that are 
responsible for controlling the process.  One of the most critical pathways involves 
Akt/mammalian target of rapamyacin (mTOR) and its activation directly influences an increase 
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in hypertrophy as well as a decrease in atrophy (Bodine et al., 2001).  Following a bout of 
resistance exercise a signal is transmitted through this mTOR pathway and activation is 
increased (Drummond, Dreyer et al., 2008).  In response to the increase of the signaling through 
this pathway, the rate of protein synthesis is consequently augmented accordingly.  Moreover, if 
this pathway is pharmacologically inhibited protein synthesis is suppressed post exercise training 
session (Kubica, Bolster, Farrell, Kimball, & Jefferson, 2005), as is muscular hypertrophy during 
overload (Bodine et al., 2001).  Akt is responsible for activating mTOR by its phosphorylation at 
Ser2448 and deactivation of mTOR occurs by the activation of the tuberous sclerosis complex 
(TSC) at the same location (Inoki, Li, Zhu, Wu, & Guan, 2002).  mTOR plays an integral role in 
protein translation, through its stimulation of initiation and elongation.  Downstream from 
mTOR, 4E-BP1 (a binding protein) is phosphorylated which allows the formation of the 
translational initiation complex eIF4F (eukaryotic initiation factor 4E; the beginning stages of 
initiation).  This deters the binding and deactivation of eIF4F and its binding to the 40S 
ribosomal subunit (Inoki et al., 2002; Kimball et al., 2002; Kimball et al., 1998).   
 Another crucial role of mTOR is its role in the activation of 70-kDa ribosomal protein 
s6kinase (p70s6k) which affects the protein synthesis process in two ways.  Initially, it stimulates 
the translation portion of protein synthesis by recruiting 5’tract of pyrimidine (5’TOP) mRNAs 
to the ribosome (Ryazanov et al., 1988).  This is crucial for the improvement of translation 
because 5’TOP mRNAs specifically encode for proteins of the ribosomal machinery itself, as 
well as for proteins such as eEF2 (Levy, Avni, Hariharan, Perry, & Meyuhas, 1991).  The other 
important function of p70s6k is to prevent the deactivation of eEF2 via eEF2k which thereby 
increases translation elongation (Ryazanov et al., 1988).   
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 Several findings indicate that the mTOR-p70S6k-eEF2 pathway may be less responsive 
to resistance exercise and/or overload in old versus young skeletal muscle.  mTOR signaling was 
decreased in old rats when compared to young when stimulated with a single bout of contractile 
activity (Funai, Parkington, Carambula, & Fielding, 2006; Parkington et al., 2004; Parkington et 
al., 2003).  Ablation surgeries of young and old rats have revealed similar findings, with mTOR 
phosphorylation being significantly elevated after an overload-induced situation in young, but 
not in older, skeletal muscles (Thomson & Gordon, 2006).  p70s6k signaling is significantly 
lower in old versus young rat skeletal muscle in response to electrical stimulation (Fick & 
Gordon, 2007).  Another key finding was that eEF2 signaling was inhibited in the old rats in 
response to electrical stimulation in that study (Fick & Gordon, 2007).  Likewise, young animals, 
after overload-induced exercise, exhibit an increase of total eEF2 protein content, while old 
muscles showed no such response (Thomson & Gordon, 2006).  A study in humans indicated 
that a resistance exercise session elicited no differences in eEF2 phosphorylation response 
between age groups after the ingestion of an essential amino acid (EAA) and carbohydrate-rich 
drink immediately prior to the exercise bout (Drummond, Dreyer et al., 2008).  However, EAA 
(especially leucine), would theoretically bypass or override AMPK signaling to directly enhance 
mTOR signaling and consequently its downstream effects, such as p70s6k phosphorylation, 
eEF2 phosphorylation, and protein synthesis (Drummond, Dreyer et al., 2008).  Interestingly, 
that study observed that the acute resistance training bout resulted in an increased of 5’-
Adenosine monophosphate-activated protein kinase (AMPK) phosphorylation (which would 
normally act as an inhibitor of mTOR signaling in the absence of the EAA drink) in the muscles 
of the older individuals, but not the young (Drummond, Dreyer et al., 2008).  This indicates the 
potential for a lower responsiveness in the protein synthesis signaling pathway due to AMPK 
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signaling under normal conditions (i.e., in the absence of EAA ingestion) and ultimately a 
potentially lower efficiency of older muscle to have a hypertrophic response to resistance 
exercise and or overload.   
AMPK 
 5’-Adenosine monophosphate-activated protein kinase (AMPK), plays an integral role in 
the regulation protein synthesis.  AMPK is located upstream from mTOR and has a negative 
effect on the initiation of protein synthesis (Bolster et al., 2002).  AMPK is a protein known for 
its function in sensing the energy balance within in the cell and responding accordingly (Winder 
& Hardie, 1999).  AMPK is activated when there is a shift in the AMP/ATP ratio and available 
ATP decreases (Winder & Hardie, 1999).  This occurs during times where ATP production is 
reduced or when ATP usage is higher, such as a bout of resistive exercise or hypoxic state 
(Hardie & Sakamoto, 2006).  AMPK is activated to fulfill two purposes.  First, it stimulates 
processes responsible for generating ATP and restores the energy balance within the cells 
(Winder & Hardie, 1999).  ATP production is increased through glycolysis, increased glucose 
uptake, fat oxidation  and mitochondrial biogenesis (Hardie & Sakamoto, 2006).   Secondly, it 
simultaneously inhibits processes that are metabolically expensive, such as protein synthesis 
(Bolster et al., 2002; Winder & Hardie, 1999).  So when AMPK senses this energy imbalance it 
inhibits mTOR signaling, and other downstream proteins that allow translation elongation and 
the recruitment of 5’TOP (Bolster et al., 2002).  AMPK is also capable of directly inhibiting 
protein synthesis by bypassing the mTOR-p70s6k pathway and stimulating eEF2k, which in turn 
inhibits eEF2 (Browne et al., 2004).  Essentially, AMPK regulates the availability of ATP for use 
and growth of the cell or promotes the production of the energy source.  Depending on the 
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AMPK activation, either diminished hypertrophy or atrophy can be expected (Gordon et al., 
2008). 
 AMPK appears to negatively regulate skeletal muscle hypertrophy and may be a reason 
underlying the diminished hypertrophy of fast-twitch muscle in older animals (Gordon et al., 
2008; Thomson & Gordon, 2005, , 2006) .  Although muscle AMPK activity has been seen to 
remain elevated 1-2 hours after an acute bout of resistive exercise in young men (Dreyer et al., 
2006), this response is more accentuated with age.  In sedentary old men at 1 hour and 3 hrs post 
resistance exercise, AMPK levels are significantly higher than seen in young men under the 
same conditions (Drummond, Dreyer et al., 2008).  These findings are consistent with old versus 
young overload induced muscle growth in Fisher 344 x Brown Norway F1 hybrid male rats 
(Thomson & Gordon, 2005).  The researchers observed a significantly higher AMPK 
phosphorylation in plantaris muscles (fast twitch) from old versus young rats, but not in the 
soleus (slow twitch) (Thomson & Gordon, 2005).  The findings also indicated a strong negative 
correlation between AMPK phosphorylation and the degree of hypertrophy in these fast twitch 
plantaris muscles (Thomson & Gordon, 2005).  These findings are all consistent with the notion 
that AMPK phosphorylation has a negative influence on mTOR and its downstream 
intermediaries and the percent of muscle hypertrophy.  The phosphorylation of mTOR is 
significantly higher in young versus old muscles after overload (Thomson & Gordon, 2006), and 
downstream markers of mTOR activity (p70s6k phosphorylation and 4E-BP1 phosphorylation) 
were negatively correlated with the increased AMPK activity with age in that study. 
To further prove whether hyperactivation of AMPK negatively regulates fast-twitch 
muscle growth in aged animals, a local perfusion of 5-aminoimidazole-4-carboxamide-1beta-D-
ribofuranoside (AICAR; an AMPK activator) was continuously administered to a fast-twitch 
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plantaris muscle of young animals (Gordon et al., 2008).  This revealed a decreased response in 
the overload-induced growth of the young fast-twitch muscle fibers.  On the contrary, old rats 
received a continuous local perfusion of an AMPK inhibitor, Compound C, on the fast-twitch 
plantaris muscle (Gordon et al., 2008).  This showed an improved growth in aged muscles, to 
levels seen in young saline treated muscle, which further confirms AMPK’s inhibitory role in 
hypertrophy (Gordon et al., 2008). 
 In addition to the possibility that the effects of AMPK inhibits skeletal muscle 
hypertrophy by inhibiting protein synthesis, AMPK may be partly responsible for the enhanced 
degradation of proteins observed in aged muscle (Nakashima & Yakabe, 2007).  Specifically, the 
initiation of forkhead box (FOXO), which is an atrophy related protein, has been linked to 
increased AMPK activation (Nakashima & Yakabe, 2007).  When these responses are compared 
between old and younger individuals there is a considerably higher activation after a bout of 
exercise in the older subjects (Raue, Slivka, Jemiolo, Hollon, & Trappe, 2007).  Although the 
protein degradation processes are not the focus of the current project, the increased atrophy-
related gene expression coupled with the decreased protein synthesis response, (all in part 
potentially due to enhanced AMPK activity) is a potential source for the atrophy and diminished 
hypertrophy in type II muscle fibers with age.   
Glycogen and Diet 
 With advancing age there tends to be a deterioration of diet and caloric intake which 
contributes to a calorically lower state associated with aging (Vanitallie, 2003).  Dietary intake of 
the elderly has been studied in attempt to identify the specific inadequacies.  Specifically, total 
calories as well as carbohydrate consumption were significantly lower in older individuals when 
compared to equally healthy young subjects (Lieberman et al., 1989).  Long term low 
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carbohydrate consumption has been associated with a reduction in glycogen stores (Astrup, 
Meinert Larsen, & Harper, 2004).  This information indicates that the elderly may be 
unintentionally consuming a low carbohydrate diet and thus lowering their total glycogen stores.   
 When individuals were placed on low carbohydrate or high carbohydrate diets, and 
performed exercise bouts, the high carbohydrate subjects were found to have a higher muscle 
glycogen content (Green, Ball-Burnett, Jones, & Farrance, 2007).  AMPK senses a shift in the 
available energy stores in the form of AMP/ATP.  AMPK sensing of energy stores can also 
extend to an intermediate reserves of energy, glycogen for example (Hardie & Sakamoto, 2006).  
Little research has examined the connection between manipulation of glycogen content and 
AMPK activity, but it is known that high levels of muscle glycogen can suppress the activation 
of AMPK by AICAR in perfused rat muscle (Wojtaszewski et al., 2002).  AMPK activity is also 
somewhat sensitive to the fuel status of the muscle in human subjects (Wojtaszewski et al., 
2003).  When young subjects were introduced to a low versus high carbohydrate diets, AMPK 
activation was significantly lower in glycogen loaded states (Wojtaszewski et al., 2003).   
Specific Aim 
Resistance training has been shown to elicit hypertrophy in young subjects, but the 
response is diminished in older individuals (Kosek et al., 2006; Raue et al., 2009).  In response to 
overload or resistance training, older humans and rats exhibit a decreased response in skeletal 
muscle activation of mTOR and p70s6k (Kumar et al., 2009; Parkington et al., 2004; Parkington 
et al., 2003; Thomson & Gordon, 2006).  In addition, older muscle shows a lower protein 
synthesis response compared to young muscle (Kumar et al., 2009).  Older rat skeletal muscle 
demonstrates a higher inhibitory phosphorylation of eEF2 when compared to younger skeletal 
muscle.  This trend seems to increase with overload, but only in the old muscle (Thomson & 
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Gordon, 2006).  Additionally, a study conducted on humans demonstrated that after consuming 
an essential amino acid and carbohydrate drink and completing a resistance exercise bout, the 
phosphorylation of eEF2 did not significantly differ between age groups (which would 
hypothetically bypass AMPK and augment the responses of mTOR and its downstream effects, 
such as p70s6k and eEF2 signaling as well as protein synthesis) (Drummond, Dreyer et al., 
2008).  The eEF2 response to acute resistance exercise has not been examined in younger versus 
older humans under normal circumstances.  Remarkably, the resistance exercise session in that 
study was sufficient to elicit an increase in AMPK phosphorylation (which would normally 
inhibit mTOR, p70s6k, eEF2, and protein synthesis in the absence of an EAA/carbohydrate 
drink) in the muscles of elderly, but not young, individuals in that study (Drummond, Dreyer et 
al., 2008).  AMPK activity has been shown to be stimulated during periods of low muscle 
glycogen content (Wojtaszewski et al., 2002).  Therefore, the lower muscle glycogen content 
(Cartee, 1994) of aged muscle could explain the increased muscle AMPK phosphorylation and 
activity that is observed in older individuals and rats at rest and in response to 
overloading/resistance exercise (Thomson 2005, Drummond 2008).  These variables could 
subsequently be contributing to the decrease in muscle mass and/or diminished anabolic response 
to resistance exercise commonly seen in aged muscle.  The aim of this study was to examine 
the eEF2 phosphorylation response to resistance exercise and its relationship to muscle glycogen 
content and AMPK activation in old versus young subjects.  We hypothesized that inhibitory 
eEF2 Thr56 phosphorylation would be higher in response to acute resistance exercise in the 
skeletal muscles of older versus younger individuals.  We further hypothesized that this higher 
eEF2 phosphorylation response would be related to higher AMPK activation, and that higher 
 
 
22 
 
AMPK activation would be related to lower muscle glycogen content, in the skeletal muscles of 
older versus younger individuals.  
 
 
 
 
CHAPTER III:  METHODS 
 
Subjects 
Participants in this study consisted of 7 young subjects (4 male and 3 female) between the 
ages of 18 and 30 years old and 10 older subjects (5 male and 5 female) between the ages 55 and 
85 years old.  Inclusion criteria included healthy, lean men and women with no known, current 
or past, cardiovascular disease, diabetes or hypertension.  Prior to participation subjects 
underwent a telephone or email prescreening to verify age, height, weight, BMI, medical history, 
current medications and exercise history.  Subjects were required to have a BMI less than, or 
close to, 30 and be physically inactive.  Inactivity was defined as engaging in less than three days 
per week of moderate intensity physical activity for more than six months prior to enrolling in 
the study.  This study was approved by the East Carolina University Institutional Review Board 
for Use of Human Subjects (APPENDIX A).  Flyers, email and word of mouth were all utilized 
around the East Carolina University (ECU) campus to recruit subjects.   
Table 3.1.  Subject Characteristics. 
 
Young Adults (n=7)     Old Adults (n=10) 
Age (years)   21.7 ± 0.8   67.0 ± 2.6* 
BMI (kg/m
2
)   23.5 ± 1.1   29.0 ± .98* 
Body Fat (%)   21.9 ± 1.9   32.6 ± 1.2* 
Fat-Free Mass (kg)  58.1 ± 4.1   57.3 ± 2.4 
Weight (kg)   74.5 ± 5.2   85.6 ± 3.5 
*=Significantly different between groups.  Data are presented as Mean + SEM (standard error of the 
mean).  Old adults were significantly older as a group and had a significantly higher BMI and body fat 
percentage.  There were no significant differences between young and old adults for fat-free mass or 
weight.  BMI: body mass index (calculated by the formula: (kg)/m
2
).  Body fat and fat free mass were 
obtained with the use of a four-site Durnin and Womersley method of skinfold measurement (Durnin & 
Womersley, 1974) 
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Experimental Design and Laboratory Visits 
The laboratory visits and associated procedures are presented in Figure 3.1.  The two 
laboratory visits were separated by one to two weeks. 
Initial Visit (non-fasted) Experimental Visit (overnight fast) 
 
 Informed consent & medical 
history 
 Height and weight measurements 
 Skinfold measurements 
 10-repetition maximum 
determination 
 Dietary recall analysis and 
counseling 
 
 Exercise session 
-Bilateral leg extension 
               -3 warm-up sets (50, 70, 90% of 10RM) 
               -3 sets to failure (100% of 10RM) 
 Biopsy- alternating legs 
-Pre-exercise, immediately post, 0 min, 60 min, 
120 min post 
Figure 3.1. 10 repetition max (10RM) was determined on the leg extension machine in the FITT building 
on the East Carolina University campus.  Warm-up sets were conducted with 10 repetitions, 5-7 
repetitions and 3-5 repetitions for each set (50%, 70%, 90% of the estimated 10RM), respectively, with 
the primary goal being muscular failure during the working sets.  The 0 min time point marks the 
completion of the last set of the resistance exercise.  60 min and 120 min post exercise biopsies are taken 
1 hour and 2 hours after the 0 min post biopsy, respectively. 
 
Initial Visit 
The initial session was held at the Fitness Instruction, Testing and Training (FITT) 
building on the campus of ECU.  This initial visit consisted of a thorough screening as well as 
gathering baseline measurements, familiarizing the participants with the exercise equipment and 
determining their individual 10 repetition maximum on the Cybex leg extension machine.   
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During the initial visit participants filled out an informed consent document, health 
history questionnaire, and a 1-day dietary recall.  Height and weight measurements were then 
taken in order to calculate BMI from the data.  Next, a 4 site skinfold measurement was taken to 
determine body density.  To remain consistent with previous research, the bicep, triceps, 
suprailiac, and subclavical skinfold sites were selected.  Then, body fat was estimated using the 
Durnin and Womersley skinfold assessment and body density formula ([495/(1.1714 – 0.063 * 
LOG[sum of skinfolds] – 0.000406 * [age]) – 450]) (Durnin & Womersley, 1974; Siri, 1961). 
The subjects then underwent a brief familiarization period with the resistance exercise 
equipment utilized during the exercise sessions to reduce the risk of injury or cardiovascular 
events due to inexperience with proper technique.  Appropriate timing and breathing for the 
concentric and eccentric phases of the exercise was be explained and demonstrated when 
necessary.  A 10 repetition maximum (10RM) was determined using the Cybex leg extension 
machine (Cybex International; Serial#: 485097W272216) during this initial visit as well.  
Subjects were asked to predict the maximum weight they could lift 10, this weight was divided 
in half for the warm-up.  If the subject was unable to estimate a 10RM a conservative weight was 
selected and the subject rated the weight on a 1-10 RPE scale.  Following the warm up, weight 
was increased between 5-20 pounds depending on the tolerance of the individual.  Each set 
consisted of 10 repetitions with a 1-2 minute rest period between sets.  Testing was terminated, 
and 10RM was determined when the participant could no longer successfully complete 10 
repetitions at the set weight.  
The subjects were provided with an information sheet containing detailed instructions for 
the 7-14 day period prior to the experimental session.  Through the duration of the experiment 
the subjects were asked to abstain from exercise or donating blood.  Two days prior to the 
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experimental visit the subjects were expected to avoid drinking alcohol, required to drink at least 
64 ounces of water daily and drink caffeine only in moderation.  Some older subjects were 
initially selected to participate in a high carbohydrate group.  These individuals were briefly 
counseled on preferred food choices to increase carbohydrate intake, and maintain protein intake, 
prior to the experimental session (see “Attempt at Dietary Intervention” for more details).  The 
subjects were instructed to drink plenty of fluids throughout the course of the study because it 
has been shown that dehydration can impair exercise performance (Shirreffs, 2005).  Caffeine 
intake was  monitored as well because it can have an ergogenic effect on performance (Burke, 
2008).  Subjects were to report for the experimental session after a 12 hour fast, and a 24 hour 
break from any exercise bouts.  Prior to arriving in the morning the subjects were required to 
drink at least 16 ounces of water.  The subjects arrived dressed for activity upon arriving at The 
East Carolina Heart Institute.   
Attempt at Dietary Intervention 
The young subjects and most of the older subjects were asked to maintain their normal 
diet throughout the course of the study.  However, three older individuals were directed to 
consume a high carbohydrate diet three days prior to the experimental session in an attempt to 
increase muscle glycogen content through dietary intervention.  During the initial visit, these 
subjects were provided guidelines and dietary counseling to assist them in making their food 
selections.  When elderly individuals are introduced into a controlled setting and able to make 
free choices in meal selection they consume approximately 30% of calories from carbohydrates 
and 50% from fats (Wurtman, Lieberman, Tsay, Nader, & Chew, 1988).  Initially, the ultimate 
goal of this investigation was to enhance muscle glycogen content via dietary intervention; 
therefore, the high CHO group was instructed to consume at least 60 to 70% of their calories 
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from carbohydrates, as well as minimize those coming from fat sources (leaving protein as 
unaltered as possible).  This required the subjects to select low fat protein and carbohydrate food 
options.  Essentially, this study design was aimed at elevating muscle glycogen content via a 
high carbohydrate diet.  The three days before the experimental session all subjects were asked to 
fill out a diet log that was analyzed using Nutritionist Pro
TM
 software (version 4.04) to assess the 
caloric consumption and dietary composition.    
Unfortunately, the attempt at accomplishing a “high CHO” group was unsuccessful, 
either due to lack of adherence or inadequate knowledge of appropriate food choices.  After 
analyzing the dietary logs for all subjects, no difference was shown between the “ad lib” group 
and the “high CHO” groups.  Table 3.2 shows a thorough breakdown of consumed calories for 
all three of the groups.  The dietary composition between the “ad lib” group and the group 
instructed to ingest a high carbohydrate diet were practically indistinguishable, and therefore 
were combined for further analysis.  Each dietary component was normalized for body weight, 
but still no significant differences were found between the age groups for any variable.  The 
mean (± SE) calorie distribution within the old group was (kcal/kg BW):  Carbohydrate, 12.3 ± 
2.3; Protein, 4.3 ± .48; and Fat, 8.0 ± 2.2.  The mean (± SE) calorie distribution within the 
young group was (kcal/kg BW):  Carbohydrate, 12.0 ± 2.1; Protein, 3.3 ± .55; Fat, 6.8 ± 3.2.  
Total kcals within the old and young groups (mean ± SE, Kcal/kg BW) were 24.4 ± 2.5 and 22.6 
± 3.5, respectively. 
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Table 3.2.  Subject Dietary Characteristics. 
 
 Old Ad Lib Old High CHO Young All Old 
 (n=5*) (n=3) (n=7) (n=8*) 
% Carb 47.0 ± 5.3 48.4 ± 5.1 53 ± 4.6  47.6 ± 3.5 
% Protein 18.2 ± 2.7 17.2 ± 1.8  17.7 ± .89 17.6 ± .89 
% Fat 34.8 ± 5.0 34.4 ± 4.2 29.7 ± 2.4 34.6 ± 3.1  
Total Kcal 1994.4 ± 259.1 1993.9 ± 68.8 1608.4 ± 183.8 1994.4 ± 139.4 
Data are presented as Mean + SEM (standard error of the mean).  The “Ad Lib” group refers to the group 
with no caloric restrictions.  The “High CHO” group was the group instructed to consume a high 
carbohydrate diet.  No significant differences were found between the Ad Lib group and the high 
carbohydrate group on any of the measures of dietary intake.  Since there was no significant difference 
between the two groups they will be combined for further analysis.  All dietary information is based on % 
Kcal of the total consumed calories.  All nutrition information was assessed using the Nutritionist Pro
TM
 
software, version 4.04.  The data from the Old “Ad Lib” group is a majority sub-sample of the entire 
group of 7.  Likewise, the data from the “All Old’ group is a majority sub-sample of the entire group of 
10.  Dietary logs were not obtained from all subjects in this group. 
 
Experimental Session 
A week or two following the initial visit, the subjects reported to The East Carolina Heart 
Institute where they were met in the lobby.  Subjects arrived fasted and prepared for a maximum 
effort on the leg extension machine.  A muscle biopsy was taken from the vastus lateralis prior to 
any work, for baseline measurements, immediately after exercise, an hour after exercise and two 
hours after exercise. Figure 3.1 outlines the procedure for the experimental session. 
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Timeline of Experimental Day 
 
            Pre-Ex   0        1 Hr  2 Hrs 
 Pre-  Exercise Session 1 Hour Post       2 Hours Post 
     Exercise Biopsy Immediately   
   Post-exercise biopsy  
 
Figure 3.2. Timeline of events on experimental day. 0 is the exercise bout, a biopsy was taken 
immediately after exercise.  1 hr is one hour after the resistance exercise bout.  2 hr is two hours after the 
exercise bout. 
 
Acute Resistance Exercise 
 The acute exercise bouts were performed on the Cybex leg extension machine (Cybex 
VR Leg Extension Model #4850, Cybex International, Medway, MA) after the first muscle 
biopsy was acquired.  Proper technique for use on the leg extension machine was discussed again 
to prevent injury.  An initial warm-up set was completed at 50% of the predetermined 10RM.  
Subjects were instructed to complete 10 repetitions for this warm-up set.  Subjects were granted 
a 1.5 minute rest interval before the commencement of the second set.  Warm-up set two was set 
at 70% of the predetermined 10RM with a completion goal of 5-7 repetitions.  Another warm-up 
interval of 1.5 minutes was allotted and the subject was instructed to complete approximately 3-5 
repetitions at 90% of their predetermined 10RM.  The typical 1.5 minute rest session was 
allocated before the first work set began at the predetermined 10RM.  The subject then 
completed three work sets until failure at the predetermined 10RM with 1.5 minutes between 
each work set.  When the subject appeared to be nearing failure verbal encouragement was 
offered and 1-3 assisted repetitions were  promoted.  In the event that a work set allows 15 or 
more repetitions the weight was increased by five to ten pounds for each succeeding set. 
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Muscle Biopsies 
 A thorough explanation of the muscle biopsy procedure was explained to the subjects 
before the commencement of the procedure.  The attending physician located the vastus lateralis 
by instructing the participant to flex the leg.  The appropriate position was marked off on both 
legs prior to the procedure and, if necessary, the location was shaved.  Three iodine swabs were 
used to sterilize the areas on the leg and a sterile field was placed over the area.  Cold spray was 
used to numb the sight for the injection of lidocaine, approximately 5 mL of 1% lidocane was 
injected subcutaneously along the vastus lateralis.  Approximately ¼ inch incision was made 
through the skin and a portion of the fascia using a No. 11 scalpel.  Muscle biopsies were 
extracted using a 5-mm Bergstrom needle, with an application of suction to maximize the muscle 
removal. 
 Immediately after each biopsy, direct pressure and an ice pack were applied to the site.  
An appropriate amount of time was given for the bleeding to terminate.  Once the bleeding 
stopped a steri strip bandage was placed on the site to hold the incision together.  Several other 
wrappings were applied to further keep the site closed, including a band aid bandage, a tegaderm 
patch, and pressure wrap.  This ensured the site healed properly, prevent water from reaching the 
incision, and result in as little scaring as possible. 
 A site was prepared on each leg prior to beginning the maximum exercise bout.  The leg 
used for the biopsies was alternated for each subsequent biopsy.  The first two biopsy sites were 
prepared at the beginning of the experimental visit.  As soon as the subject completed the 
exercise session they were immediately moved back to the bed for the next biopsy, time point 0.  
Precisely one hour later the third biopsy was taken bilaterally, 5 cm proximally from the first, 
pre-exercise biopsy.  The last biopsy was taken from the other leg proximal to biopsy two at 
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precisely 120 minutes after the exercise session.  Each biopsy was allotted a new incision site 
that was sterilized in the same manner as the first two.  Immediately after the biopsy was 
extracted from the leg, it was flash-frozen in liquid nitrogen and stored in a cryovial at -80° C 
until it was later used for western blotting analyses.   
Sample Analyses 
 The muscle glycogen content was assessed by combining numerous methods from 
Passonneau and Lauderdale (1974), Passonneau and Lowry (1993), and Roy and Tarnopolsky 
(1998).  Specifically, 5-15 mg of each sample of muscle were homogenized on ice in 53.3 
volumes (3 mg/160 µL) of 0.1 M NaOH in a ground glass homogenizer.  A 100 µL aliquot of 
every sample was neutralized with 100 µL of 0.2 M acetic acid and vortexing.  Subsequently, 
two 50-µL aliquots of each of the samples were placed into duplicate tubes containing 200 µL of 
0.1 M sodium acetate buffer (0.05 M acetic acid; 0.05 M sodium acetate, pH 4.6-4.7).  Each 
remaining step was accomplished in a facsimile manner.  In order to obtain free glucosyl units, 
glyogenolysis was then achieved by adding 10 µL of amyloglucosidase (10 µL/mL in 20 mM 
Tris buffer and 0.02% bovine serum albumin, pH 7.5; specific activity= 25.9 U/mg; Sigma-
Aldrich # A7420, St. Louis, MO), followed by vortexing, and incubating at room temperature for 
1 hour.  The samples were then refined from any precipitate remaining in suspension by 
centrifugation at 16000 x g for 5 minutes.  A commercially available glucose assay (based upon 
hexokinase and glucose-6-phosphate dehydrogenase reactions; Sigma-Aldrich # GAHK20) was 
then performed to establish the amount of free glucosyl units in each sample.  The muscle 
glycogen content (µL/mg wet weight) of the original sample was then derived by comparing it to 
a standardized curve made with type III glycogen from rabbit liver (Sigma-Aldrich #G8876), 
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which were manipulated in the exact same way as the muscle samples in the present study, 
starting with the NaOH step. 
AMPK phosphorylation, p70S6k phosphorylation, and eEF2 phosphorylation was 
assessed by western blotting technique to analyze the signaling proteins.  The primary antibodies 
used to detect total and phospho-proteins are all commercially available: anti-AMPK [Cell 
Signaling Technology (CST); Danvers, MA; Cat. # 2532], rabbit monoclonal anti-phospho-
AMPK (CST; Cat. # 4188), anti-acetyl CoA Carboxylase (streptavidin-HRP, GE Life Sciences, 
RPN1231), anti-phospho-Acetyl CoA carboxylase (Millipore Corporation; Temecula, CA; Cat. # 
07-303), anti phospho-eEF2 (CST; Cat. # 2331), and anti total-eEF2 (CST; Cat. # 2332).  A 
portion of each frozen muscle biopsy sample was homogenized using a buffer that consists of 50 
mM HEPES (pH 7.4), 0.1% Triton X-100, 4 mM EGTA, 10 mM EDTA, 15 mM 
Na4P2O7•10H2O, 100 mM ß-glycerophosphate, 25 mM NaF, 50 µg/ml leupeptin, 50 µg/ml 
pepstatin, and 33 µg/ml aprotinin.  A ground glass homogenizer using a motor with variable 
speeds was used to perform all homogenizations.  Homogenizations were performed on ice in 
order to prevent excessive heat build-up that may denature proteins.  Total muscle protein 
homogenates were solubilized in sample loading buffer (50 mM Tris-HCl, pH 6.8, 10% glycerol, 
2% SDS, 2% ß-mercaptoethanol, 0.1% bromophenol blue) at a concentration of 1 mg/ml and 
boiled for 5 min.  Proteins were then separated by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) on multiple gels using various acrylamide percentages and 
gradients depending upon the molecular weights of the various proteins of interest, then western 
blotted for 2 hours at 4˚C onto a PVDF membrane at 100V in transfer buffer (25 mM Tris-base 
pH~8.3, 192 mM glycine, 20% methanol).  Membranes were stained by Ponceau S to verify 
equal loading amongst lanes.  For immunodetection, membrane strips were blocked for 1 hr in 
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blocking buffer [5.0% nonfat dry milk in TBS-T (20 mM Tris-base, 150 mM NaCl, 0.1% 
Tween-20), pH 7.6] then incubated overnight at 4ºC with primary antibody (1:1000 dilution in 
TBS-T with 5% BSA) overnight at 4º. The membranes were then serially washed in TBS-T, 
incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (Amersham 
Biosciences, Piscataway, NJ) in blocking buffer for 1 hr, and again serially washed in TBS-T.  
The HRP activity was detected using enhanced chemiluminescence reagent (Amersham 
Biosciences, Piscataway, NJ) and exposure to autoradiographic film.  The IODs was then 
quantified by densitometry (Gel-Pro Analyzer, Media Cybernetics, Silver Spring, MD) and the 
concentration of the antigen present in each muscle was calculated as the IOD normalized to 
units of total muscle protein initially loaded on the gel.  It should be noted that western blotting 
analysis was also attempted for phospho-p70s6k, but no bands were observed. 
Statistics 
 An analysis of variance (ANOVA) with repeated measures was utilized to analyze the 
differences between and within the various groups using Statistica, version 6 (StatSoft, Inc., 
Tulsa, OK).  The percent change data was evaluated using a one-way ANOVA.  Post-hoc 
differences were determined by using Fisher’s LSD Post-hoc test.   Pearson Product-moment 
correlations were used for all correlational analyses.  The significance level was set at an alpha 
level of p ≤ 0.05. 
  
 
 
 
 
 
CHAPTER IV:  RESULTS 
Subject Strength and Work Volumes 
 All subjects successfully completed the initial and experimental sessions.  Performance 
for the exercise bouts were measured by total and relative volume for each group.  The total 
volume was calculated by multiplying the total amount of weight lifted during the work sets by 
the number of completed repetitions during the experimental visit.  Relative volume was 
standardized to fat free mass (kg) in order to represent the relative amount of weight lifted (data 
presented in Table 4.1). 
Table 4.1.  Assessment of Ten-repetition Maximum Strength and Work Volume Between Young 
and Old Adults 
       
Young Adults (n=7)           Old Adults   (n=10) 
 
Estimated 10 RM (kg) 48.53 ± 5.3 34.9 ± 3.4*  
Total volume 1644 ± 223       1167 ± 183 
(kg resistance x repetitions)    
 
Relative volume  28 ± 1.9 19 ± 1.8* 
(kg resistance/kg FFM) 
 
*= Significantly different between groups.  Data are represented as Means ± SEM (standard error of the 
mean).  Older adults had significantly lower estimated 10 RM and relative volumes.  Total volume (kg 
resistance) was calculated to evaluate the absolute amount of weight lifted during the working sets by 
each subject using the equation:  Total volume = [(resistance set 1(kg) x repetitions set 1) +(resistance set 2(kg) 
x repetitions set 2) + (resistance set 3(kg) x repetitions set 3)].  Total volume was standardized by fat free mass 
to show the amount of weight lifted relative to lean body mass:  relative volume = total volume (kg 
resistance) / fat free mass (kg). 
 
Western Blotting Analysis 
 The present study aimed to determine the response of eEF2 phosphorylation at Thr56 to 
resistance exercise and its relation to muscle glycogen content and AMPK activation in the 
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skeletal muscle of young versus old individuals.  It was hypothesized that inhibitory eEF2 Thr56 
phosphorylation would be elevated in response to an acute resistance training session in the 
skeletal muscles of older versus younger individuals.  It was further hypothesized that this higher 
eEF2 phosphorylation response would be related to a higher AMPK activation, and that higher 
AMPK activation would be related to lower glycogen content, in the skeletal muscles of older 
versus younger individuals.  To assess AMPK activity, we measured acetyl oCoA carboxylase 
(ACC), an indicator of in vivo AMPK activity (Winder et al., 1997).   
Glycogen 
 Muscle glycogen content was assessed at the PRE and all three post exercise time points 
for each of the groups.  There was a significant difference in glycogen content between the 
young and old groups at PRE exercise.  After the acute bout of resistance exercise both groups 
revealed a significant decrease in glycogen content at all time points within each individual age 
group, with no differences between groups after exercise (Figure 4.1). 
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Figure 4.1. Mean ± SEM Muscle Glycogen Content in young and old subjects.  Pre represents the pre 
exercise muscle biopsy, 0P is the immediately post exercise biopsy, 1P is the one hour post exercise 
muscle biopsy, and 2P is the two hour post exercise muscle biopsy.   The young had significantly greater 
muscle glycogen content compared to the old at the PRE time point.  The young and old subjects had 
significantly different muscle glycogen contents at all post exercise time points compared to the PRE time 
point within the individual age groups.  Significance is set at p ≤ 0.05. 
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AMPK 
 The old group had a significant increase in AMPK phosphorylation at Thr
172 
at the 0P 
time point compared to the PRE exercise value (Figure 4.2), but the young group had no such 
increase.  There were no significant effects of age or time point on total AMPK (Figure 4.3).  
The phospho/total AMPK ratio revealed a significant main effect of time point at the 0P versus 
PRE exercise time point for both groups combined (Figure 4.4), but no effect of age.    
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Figure 4.2.  Mean ± SEM phospho-AMPK at Thr172 in young and old subjects and the representative 
western blots.  PRE is the pre exercise muscle biopsy, 0P is the immediately post exercise muscle biopsy, 
1P is the one hour post exercise muscle biopsy, and 2P is the two hour post exercise muscle biopsy.  
Phospho-AMPK was significantly increased from the PRE time point to the 0P time point within the old 
group.  Significance is set at p ≤ 0.05. 
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 Figure 4.3.  Mean ± SEM Total AMPK in young and old subjects and the representative western blots.  
PRE is the pre exercise muscle biopsy, 0P is the immediately post exercise muscle biopsy, 1P is the one 
hour post exercise muscle biopsy, and 2P is the two hour post exercise muscle biopsy.  Total AMPK was 
not significantly different between age groups or from the PRE exercise time point.  Significance is set at 
p ≤ 0.05. 
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Figure 4.4.  Mean ± SEM phospho/total AMPK ratio in young and old subjects and the representative 
western blots.  PRE is the pre exercise muscle biopsy, 0P is the immediately post exercise muscle biopsy, 
1P is the one hour post exercise muscle biopsy, and 2P is the two hour post exercise muscle biopsy.  
Phospho/total AMPK had a significant main effect of time point at 0P versus the PRE time point for both 
young and old groups combined.  Significance is set at p ≤ 0.05. 
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ACC 
 Acetyl CoA carboxylase (ACC), an in vivo indicator of AMPK activation (Winder et al., 
1997), showed a significant main effect of time point in phosphorylation status at Ser
79
 
immediately post exercise (0P) and at one hour post exercise (1P) (Figure 4.5) for both young 
and old groups combined.  The same significant main effect of time point was seen in total ACC 
(decreased; Figure 4.6) and phospho/total ACC (increased; Figure 4.7) for both the 0P and 1P 
time points for both age groups combined.  No differences existed between the age groups for 
phospho-ACC (Figure 4.5), total ACC (Figure 4.6) or phospho/total ACC (Figure 4.7). 
 
  
 
 
42 
 
 
  
 
Young  
 
Old  
 
 PRE 0P 1P 2P 
 
Figure 4.5.  Mean ± SEM phospho-ACC at Ser79 in young and old subjects and the representative western 
blots.  PRE is the pre exercise muscle biopsy, 0P is the immediately post exercise muscle biopsy, 1P is 
the one hour post exercise muscle biopsy, and 2P is the two hour post exercise muscle biopsy.  Phospho-
ACC had a significant main effect of time point at 0P and 1P versus the PRE time point for both young 
and old groups combined.  Significance is set at p ≤ 0.05. 
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Figure 4.6.  Mean ± SEM total ACC in young and old subjects and the representative western blots.  PRE 
is the pre exercise muscle biopsy, 0P is the immediately post exercise muscle biopsy, 1P is the one hour 
post exercise muscle biopsy, and 2P is the two hour post exercise muscle biopsy.  Total ACC had a 
significant main effect of time point at 0P and 1P versus the PRE time point for both young and old 
groups combined.  Significance is set at p ≤ 0.05. 
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Figure 4.7.  Mean ± SEM phospho/total ACC  in young and old subjects.  PRE is the pre exercise muscle 
biopsy, 0P is the immediately post exercise muscle biopsy, 1P is the one hour post exercise muscle 
biopsy, and 2P is the two hour post exercise muscle biopsy.  Phospho/total ACC had a significant main 
effect of time point at 0P and 1P versus the PRE time point for both young and old groups combined.  
Significance is set at p ≤ 0.05. 
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Phospho-ACC (Ser79) Correlations with Muscle Glycogen Content 
 The relationship between phospho-ACC and muscle glycogen content was examined at 
the PRE, 0P, 1P, and 2P time points.  Under baseline conditions, or at the PRE exercise time 
point, no significant relationship exists between muscle glycogen content and the 
phosphorylation status of ACC at Ser
79
 (Figure 4.8).  At the 0P and 1P time points, significant or 
near-significant correlations of -0.44 (p=0.07) and -0.64 (p=0.006) indicated a negative 
relationship between muscle glycogen content and phospho-ACC at those time points (Figures 
4.9 and 4.10).  This indicates that when muscle glycogen content is higher, the phosphorylation 
of ACC at Ser
79 
is lower one to two hours after resistance exercise.  The relationship between 
phospho-ACC (Ser79) and muscle glycogen content is negative at all time points except the 2P 
time point, where it is non-significantly positive.  The relationship between muscle glycogen 
content and phospho (Ser79)/ total ACC ratio demonstrated a similar pattern:  r = -0.43, p = 
0.076 at PRE; r = -0.45, p = 0.06 at 0P; r = -0.69, p = 0.002 at 1P; and r = 0.02 (N.S.) at 2P. 
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Figure 4.8.  Relationship between glycogen content and phospho-ACC (Ser79) in the vastus lateralis 
muscles of young and old subjects prior to an acute bout of resistance exercise. 
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Figure 4.9.  Relationship between glycogen content and phospho-ACC (Ser79) in the vastus lateralis 
muscles of young and old subjects immediately after an acute bout of resistance exercise. 
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Figure 4.10.  Relationship between glycogen content and phospho-ACC (Ser79) in the vastus lateralis 
muscles of young and old subjects 1 hour after an acute bout of resistance exercise. 
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Figure 4.11.  Relationship between glycogen content and phospho-ACC (Ser79) in the vastus lateralis 
muscles of young and old subjects 2 hours after an acute bout of resistance exercise. 
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eEF2 
 eEF2 phosphorylation at Thr
56
 was not significantly different between age groups, but a 
main effect of time point was significant at all post exercise time points compared to the PRE 
time point for both the young and old groups combined (Figure 4.12).  Likewise, total eEF2 did 
not have significant differences between the age groups, but there also was a significant main 
effect of time point at all post exercise time points compared to pre exercise (Figure 4.13).  
Similar findings were seen with the ratio of phospho/total eEF2, exhibiting no significant 
differences between the age groups.  There was, however, a significant main effect of all time 
points versus the PRE time point for phospho/total eEF2 (Figure 4.14).   
  
 
 
51 
 
PRE 0P 1P 2P
0
100
200
300
400
Young
Old
Phospho-eEF2 (Thr56)
Time Point
#
# #
In
te
g
ra
te
d
 O
p
ti
c
a
l 
D
e
n
s
it
y
  
(a
rb
it
ra
ry
 u
n
it
s
)
 
 
 
 
 
 
 
 
 
 
 
 Young 
 
Old 
 
 PRE 0P 1P 2P 
 
Figure 4.12.  Mean ± SEM phospho-eEF2 (Thr56) in young and old subjects and the representative 
western blots.  PRE is the pre exercise muscle biopsy, 0P is the immediately post exercise muscle biopsy, 
1P is the one hour post exercise muscle biopsy, and 2P is the two hour post exercise muscle biopsy.  
Phospho-eEF2 had a significant main effect of time point at 0P,1P and 2P versus the PRE time point for 
both young and old groups combined.  Significance is set at p ≤ 0.05. 
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Figure 4.13.  Mean ± SEM total eEF2 in young and old subjects and the representative western blots.  
PRE is the pre exercise muscle biopsy, 0P is the immediately post exercise muscle biopsy, 1P is the one 
hour post exercise muscle biopsy, and 2P is the two hour post exercise muscle biopsy.  Total eEF2 had a 
significant main effect of time point at 0P, 1P and 2P versus the PRE time point for both young and old 
groups combined.  Significance is set at p ≤ 0.05. 
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Figure 4.14.  Mean ± SEM phospho/total eEF2 (Thr56) in young and old subjects.  PRE is the pre 
exercise muscle biopsy, 0P is the immediately post exercise muscle biopsy, 1P is the one hour post 
exercise muscle biopsy, and 2P is the two hour post exercise muscle biopsy.  Phospho/total eEF2 had a 
significant main effect of time point at 0P, 1P and 2P versus the PRE time point for both young and old 
groups combined.  Significance is set at p ≤ 0.05. 
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Phospho-ACC (Ser79) Correlations with Phospho-eEF2 (Thr56) 
 The relationship between phospho-ACC and phospho-eEF2 content was examined at the 
PRE, 0P, 1P, and 2P time points.  Under baseline conditions, or at the PRE exercise time point, 
no significant relationship existed between the phosphorylation status of ACC at Ser
79
 and the 
phosphorylation status of eEF2 at Thr
56
 (Figure 4.15).  At the 0P and 1P time points, significant 
or near-significant correlations of 0.49 (p=0.048) and 0.65 (p=0.005) indicated a positive 
relationship between phospho-ACC and phospho-eEF2 at those time points (Figures 4.16 and 
4.17).  This indicates that within at least the first hour after a bout of resistance exercise, the 
phosphorylation of ACC at Ser
79
 is correlated with an increase in phosphorylation of eEF2 
(Thr
56
) phosphorylation (an indication of less activity for eEF2 at those time points).  The 
relationship between phospho-ACC (Ser79) and phospho-eEF2 (Thr
56
) was lost by 2 hours post-
exercise.    
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Figure 4.15.  Relationship between phospho-ACC (Ser79) and phospho-eEF2 (Thr56) in the vastus 
lateralis muscles of young and old subjects prior to an acute bout of resistance exercise. 
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Figure 4.16.  Relationship between phospho-ACC (Ser79) and phospho-eEF2 (Thr56) in the vastus 
lateralis muscles of young and old subjects immediately after an acute bout of resistance exercise. 
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Figure 4.17.  Relationship between phospho-ACC (Ser79) and phospho-eEF2 (Thr56) in the vastus 
lateralis muscles of young and old subjects 1 hour after an acute bout of resistance exercise. 
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Figure 4.18.  Relationship between phospho-ACC (Ser79) and phospho-eEF2 (Thr56) in the vastus 
lateralis muscles of young and old subjects 2 hours after an acute bout of resistance exercise. 
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CHAPTER V:  DISCUSSION 
 The aim of this study was to examine the eEF2 phosphorylation response to resistance 
exercise and its relation to muscle glycogen content and AMPK activation in old versus young 
subjects.  We hypothesized that inhibitory eEF2 Thr56 phosphorylation would be higher in 
response to acute resistance exercise in the skeletal muscles of older versus younger individuals.  
We further hypothesized that this higher eEF2 phosphorylation response would be related to 
higher AMPK activation, and that higher AMPK activation would be related to lower muscle 
glycogen content, in the skeletal muscles of older versus younger individuals.   At rest, the old 
had significantly lower muscle glycogen levels compared to the young men and women.  After 
the resistive leg extensions, both groups had a significant decrease in the level of muscle 
glycogen content, with no difference between age groups at the post-exercise time points.  
AMPK phosphorylation was significantly increased from the baseline measurement after the 
resistive leg extensions within the old group, but not in the young group.  However, ACC 
phosphorylation (indicating in vivo AMPK activity) showed no difference between age groups, 
with a significant main effect increase for both groups after the acute bout of exercise up to one 
hour post-exercise.  Likewise, there was a significant main effect of eEF2 phosphorylation after 
the acute bout of resistance exercise, but again, no significant differences were seen between the 
groups.  AMPK activity (as assessed by phospho-ACC, which is a better indicator of AMPK 
activity) was negatively correlated with muscle glycogen content immediately and up to one 
hour after the exercise session, and eEF2 phosphorylation was positively correlated with AMPK 
activity during that same time period.   
 The primary findings of the current study could have larger implications that help 
understand the specific portion of the protein synthesis signaling pathway on which we 
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concentrated for this investigation.  After a bout of resistance training, an increase in AMPK 
activity may be related to a decrease in post-exercise glycogen content in fasted individuals.  
Wojtaszewski et al. compared the effects of muscle glycogen content to AMPK activity after a 
bout of exercise and observed a similar relative decrease in glycogen content after an exercise 
session (Wojtaszewski et al., 2003). That same study indicated that while exercising during times 
of high muscle glycogen content AMPK activity was reduced, and the opposite was true for low 
muscle glycogen content (Wojtaszewski et al., 2003).   Elevated AMPK phosphorylation as 
observed in aged rat fast-twitch muscle during overload is associated with a diminished response 
in various indicators of the protein synthesis pathway, specifically eEF2 phosphorylation 
(Thomson & Gordon, 2006).   In this study, regardless of age, higher muscle glycogen content 
was associated with lower AMPK activity (as assessed by phospho-ACC content) at 0P and 1P, 
and this lower AMPK activity was associated with lower inhibitory phosphorylation of eEF2 at 
those same time points.  These findings indicate the possibility that higher muscle glycogen 
content may result in lower AMPK activation and consequently lower inhibitory eEF2 
phosphorylation in response to a resistance training session in the muscles of both younger and 
older individuals, thereby potentially enabling greater translation elongation, protein synthesis, 
and muscle growth regardless of age.  Since muscle glycogen may play a role in AMPK activity 
after an acute bout of resistance training, the fact that glycogen content was similar between 
young and old at all post-exercise time points could explain why no differences were also seen in 
ACC or eEF2 phosphorylations between the age groups. 
 Previous research has indicated that AMPK activation in response to aerobic exercise was 
significantly lower under higher levels of muscle glycogen (Wojtaszewski et al., 2003).  This 
indicates that AMPK may be in part regulated by the available fuel status in the muscle in the 
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form of glycogen.  Similarly, the present study found a negative relationship between muscle 
glycogen content and AMPK activity, (as assessed by phospho-ACC level and phospho/total 
ACC ratio) immediately following resistance exercise and remaining for at least an hour after 
exercise.  Thus, one potential contributor to increased AMPK activity in the hour following 
exercise may be the amount of glycogen present within the muscle.  Nevertheless, while muscle 
glycogen content may play a role, it cannot be the only cause for the increase in AMPK activity 
in this investigation due to the fact that while glycogen content remains low 2 hours after 
exercise phospho-ACC content returns to baseline.  In this accord, it is known that another (and 
primary) mechanism resulting in AMPK activation is the imbalance in AMP/ATP ratio (Winder 
& Hardie, 1999), which can increase in response to a session of resistance training (Hardie & 
Sakamoto, 2006).  Consequently, AMPK phosphorylates (an activation mechanism) and 
activates intermediates that block protein synthesis in attempt to replenish ATP and conserve 
energy (Hardie & Sakamoto, 2006). 
It has previously been observed that old rats have a significantly greater decreases in 
muscle glycogen levels when compared to their young counterparts (Cartee, 1994; Hopp, 1996).  
In contrast, the present study in humans noticed no significant differences in muscle glycogen 
content between the ages other than at baseline.  The old have a significantly lower baseline 
measurement of muscle glycogen, but both groups decrease to amounts that are 
indistinguishable.  Previous research in humans has also indicated a significant difference exists 
in AMPK phosphorylation between old and young men at various time points after an exercise 
bout (Drummond, Dreyer et al., 2008).  Although the present study found that the older subjects 
tended to have higher levels of phospho-AMPK across all timepoints, this was not statistically 
significant.  However, there was a significant increase from baseline in phospho-AMPK within 
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the old group immediately after an acute bout of resistance training, an effect not observed in the 
young group.  Drummond and Dryer, (2008), utilized only men, while the current study used 
both women and men, although they later concluded that sex does not play a role in the 
responses of protein synthesis to an acute bout of exercise (Dreyer et al.).  This is in 
correspondence with our findings, in that no significant differences were observed between the 
genders (data not shown).  They also observed the phosphorylation of AMPK to be elevated at 
one and three hours after the resistance exercise bout (Drummond, Dreyer et al., 2008).  Once 
again this differs from the present study in that the differences were most pronounced 
immediately after the exercise, with no significant differences at one or two hours post.  It is 
unclear as to why the present study did not see similar results extending past the 1P time point.  
It can be speculated that the essential amino acid ingestion performed by subjects in the 
Drummond et al. study may have played a role in the signaling responses of AMPK and other 
variables in that study.  
AMPK is directly responsible for the phosphorylation of ACC at Ser
79
 (Park et al., 2002), 
which is used as a marker of in vivo AMPK activity (Hawley et al., 1996).  After inducing one 
week of overload conditions in rats, ACC and AMPK exhibit similar phosphorylation responses 
(Thomson & Gordon, 2005).  However, this is not necessarily always the case.  For example, 
AMP can enhance the activity of AMPK via allosteric binding in the absence of changes in 
AMPK phosphorylation (Winder & Hardie, 1999).  A prime example of this is after a high 
frequency exercise stimulus and AICAR, an AMPK activator, the phosphorylation of ACC was 
higher compared to AMPK phosphorylation (Thomson et al., 2009).  In the present study, 
phospho-AMPK was only increased at the 0P time point, and only in old; however, 
phosphorylation of ACC (Ser79) remained significantly elevated (main effect) at the 1P time 
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point for both age groups.  Therefore, AMPK activity may not be able to be completely inferred 
by AMPK phosphorylation alone, and could be influenced by other factors, such as the allosteric 
influence of AMP.  It must also be noted that other aspects of metabolism during the post-
exercise recovery period (such as lactic acid, fat oxidation, etc.) may have influenced the 
variables being measured, but those metabolic aspects were not assessed in this investigation. 
 Dreyer et al. observed a significant decrease in the phosphorylation of eEF2, and thus 
theoretically more eEF2 activity, during the post exercise recovery period at both one and two 
hours compared to baseline in young human subjects (Dreyer et al.).  The current study 
witnessed the same pattern in phosphorylation status of eEF2, and no differences with age.  A 
previous study has also indicated no significant difference in eEF2 phosphorylation between the 
age groups after resistance exercise, but subjects ingested an EAA/CHO supplement after the 
exercise session in that study (Drummond, Dreyer et al., 2008).  Thus, we postulated that eEF2 
phosphoryaltion would differ with age if an EAA ingestion were not influencing mTOR 
signaling.  However, this was not the case, as eEF2 phosphorylation responded similarly in both 
young and old subjects in the current study under normal (non-EAA) conditions.  It is important 
to point out that this is the first study on human subjects that compared the effects of eEF2 in 
young and old individuals after an acute bout of resistance training, while under normal 
conditions.  Previous studies have observed a significant difference in eEF2 phosphorylation 
status between young and old rats (Fick & Gordon, 2007; Thomson & Gordon, 2006), but such 
results did not translate to humans under the conditions of the current investigation. 
While this study only examined the recovery period for two hours, Drummond et al. have 
indicated that this same elevated AMPK phosphorylation response in old (but not young) 
subjects can be seen up to three hours after an exercise bout (Drummond, Dreyer et al., 2008).  
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While the current investigation also observed an elevated AMPK phosphorylation response only 
in old subjects, AMPK activity was elevated immediately, and for at least one hour, after 
exercise in both young and old subjects.  Similarly, research by Dreyer et al. indicated that 
AMPK activity was significantly increased immediately, and at one hour after a resistance 
exercise in young men and women, with the phosphorylation of eEF2 being significantly reduced 
at 1 and 2 hours post-exercise (Dreyer et al., 2006).  The current study also observed a very 
similar suppression of eEF2 phosphorylation at those same time points.  In both studies, the 
highest AMPK activity (immediately post-exercise) corresponded to an elevated eEF2 
phosphorylation.  In fact, AMPK activity was significantly correlated with eEF2 phosphorylation 
immediately and 1 hour post-exercise in the current study.  Collectively, the above results 
indicate that AMPK may partially control eEF2 phosphorylation in response to resistance 
exercise regardless of age, especially immediately after (and perhaps during) exercise.  There are 
multiple mechanisms by which AMPK activation may up-regulate eEF2 phsophorylation.  One 
possibility is suppression of mTOR-p70s6k signaling, which would suppress inhibitory 
phosphorylation of eEF2 kinase (thus resulting in increased eEF2 phosphoryaltion) (Thomson & 
Gordon, 2006).   Another is a direct effect of AMPK on eEF2 kinase (Fick & Gordon, 2007).  
Studies have indicated a difference in the activity in p70s6k with age status, old having lower 
activations (Fick & Gordon, 2007; Kumar et al., 2009; Thomson & Gordon, 2006).  Since 
p70s6k is located upstream from eEF2, it theoretically can alter the response of eEF2 (Thr56).  
While the present study did not measure p70s6k, we initially would have anticipated finding a 
difference between ages with p70s6k activity.  However, the present study found no age 
differences in eEF2 phosphorylation, therefore, either p70s6k did not affect eEF2 
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phosphorylation differently between age groups, or other compensatory mechanisms came into 
play.   
 The phosphorylation status of eEF2 is incredibly influential in the translation elongation 
segment of protein synthesis.  The body decreases protein synthesis during the exercise bout and 
in turn increases it during the recovery period (Phillips et al., 1997).  In the present study, the 
increase in total eEF2 coupled with decrease in phospho-eEF2 is evidence that the muscle is 
encouraging translation elongation, and thereby protein synthesis.  The significant increase (main 
effect) of the phosphorylation of eEF2 at the 0P time point is indicative of less activity, and 
likewise, the significantly lower (main effect) levels observed during recovery indicate increased 
activity.  Protein synthesis, being the energy expensive pathway that it is (Thomson & Gordon, 
2005), could also account, in part, for the decrease in muscle glycogen content during the 
recovery period.  Once again, because the glycogen levels do not change from 0P to 1P, while 
the P-eEF2 has a huge change to favor protein synthesis, it is likely that glycogen is not the only 
factor, and that the acute changes in AMP (and subsequent changes in AMPK activation) are also 
a prime contributor. 
 In the current study there were no differences between the dietary intakes of young and 
old subjects on any of the components.  In other studies it has been shown that not only do older 
individuals consume fewer calories, but also fewer calories come from carbohydrates 
(Lieberman et al., 1989).  It is possible that the discrepancy between the present and previous 
findings is due to individual variability in dietary log completion.  However, another possible 
reason for the difference between these findings in dietary intake could be due to the fact that 
Lieberman et al. adjusted their dietary data for differences in body weight (Lieberman et al., 
1989).  Once the current study normalized for body weight, there still were no differences on any 
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of the dietary components between the age groups.  We can further speculate that differences 
between the current study and the findings of Lieberman et al. could be attributed to various 
factors, including geographic location, time of year, financial burden of the individual, or time 
constraints influencing food choices.   
 There were significant differences in strength between the young and old subjects.  The 
older subjects had significantly lower 10RM scores, both on and absolute basis as well as 
normalized to fat free mass.  These findings are dissimilar to the findings of Drummond and 
Miyazaki, 2008, who that found no significant differences between strength between old and 
young subjects when compared to lean body mass (Drummond, Miyazaki et al., 2008).  The 
difference between their findings and ours could be a result of the subjects that were selected for 
participation.  The young subjects in the current study may not have been motivated to put forth 
a maximal effort.  They also may not have participated with concern for the outcome of the 
study, but more for the financial compensation that resulted from participation, once again 
leading to decreased effort.  While the total work volume in the current study was not 
significantly different, it is nevertheless reduced by 27% with age.  The lack of statistical 
difference in total volume between older vs. younger individuals may be due to higher 
percentage of slow twitch muscle fibers in age (Hortobagyi et al., 1995), potentially leading to 
more endurance and thus higher repetitions. 
 The initial aim of this study intended to explore potential differences in AMPK activity, 
eEF2 phosphorylation and muscle glycogen content between age groups, and the only variable 
for which was found a significant difference was muscle glycogen content at baseline.  This lack 
of differences in any the previously mentioned measures may be attributed to numerous causes.  
For example, the present study recruited healthy older individuals whom were relatively free 
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from medications at an advanced age.  This sample of individuals may be healthier and therefore 
not representative of the normal aged population.  Secondly, the young subjects recruited were 
all inactive individuals and could have been unfamiliar with exercise and therefore might have 
not given their true maximum effort.  These subjects may have felt exercise to be uncomfortable 
and therefore exercised below that of which they were capable.  Lastly, all subjects were fasted, 
so the difference between the young and old subjects may not be pronounced in a fasted state (Li 
& Goldberg, 1976).   
Some limitations of this study should be addressed for future studies.  First, the subjects 
underwent a brief dietary counseling and were provided a dietary guide to help them make 
appropriate high carbohydrate, low fat choices.  After analyzing the diets there was no significant 
difference between diets of the “normal” and “high carbohydrate” individuals.  It is possible that 
while each individual indicated that they understood the directions of the high carbohydrate diet, 
they may not have been sure of how to change their diet so drastically.  If the individuals would 
have been provided the same food, we could have eliminated subject error and determined 
whether a three day high carbohydrate diet would in fact decrease the activation of AMPK in the 
elderly.  Second, as previously mentioned, the subjects were requested to fill out a diary of 
everything they consumed for the three days prior to reporting to the lab.  This could have had an 
effect on what and how much the individuals ate.  The older individuals could have 
overcompensated in their diet to attempt to fulfill the requirements of the study.   
While the present study did not successfully accomplish a high carbohydrate diet, other 
methods of increasing muscle glycogen content via diet in conjunction with resistance training 
would be beneficial to investigate.  Manipulation of dietary intake may be a cost-effective 
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solution to combat the negative consequences of age associated muscle atrophy and diminished 
overload-induced hypertrophy.   
In summary, we show a relationship between lower muscle glycogen content and 
elevated AMPK activity immediately and for at least one hour following resistance exercise in 
fasted young and old men and women.  Moreover, higher AMPK activity was associated with 
higher eEF2 phosphorylation (and presumably inhibited eEF2 activity) during that same post-
exercise time period.  Although it has also been previously observed that elevated AMPK 
phosphorylation in aged muscle is associated with a diminished eEF2 response (Thomson & 
Gordon, 2006), we saw no difference in the responses of AMPK activity or eEF2 phosphorylaton 
between age groups in the current investigation.  Nevertheless, regardless of age, the current 
results indicate that lower glycogen content could play a role in enhancing AMPK activation, 
which in turn could enhance post-exercise eEF2 phosphorylation (and thus suppress eEF2 
activity) in fasted individuals regardless of age.  Additional research should be conducted to 
determine whether a state of high glycogen content is capable of eliciting lower AMPK and ACC 
phosphorylation levels.  It would also be beneficial to include older individuals with varying 
health statuses to determine whether a lower functioning individual, with a more accelerated 
level of sarcopenia, can elicit greater differences between the ages.  Also, more studies should be 
conducted to determine the correlational significance between protein synthesis intermediaries 
(such as mTOR, p70S6k and eEF2) and muscle glycogen content.   
 
Practical Application 
Potentially, individuals with advanced stages of sarcopenia could benefit merely from the 
ingestion of a diet higher in carbohydrates and kcals, or other strategies that may enhance muscle 
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glycogen content.  Not only would this combat the age-related deterioration in muscle, but also 
could prevent the loss of mobility, due to lack of strength, in later years.  It is possible that 
keeping muscle glycogen at a high level, independent of age, could help promote the activation 
of the protein synthesis pathway and muscular strength. 
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APPENDIX B:  INFORMED CONSENT DOCUMENT 
Principal Investigator:  Scott E. Gordon, Ph.D. 
Institution:  Human Performance Laboratory 
Address:  363 Ward Sports Medicine Building 
Telephone #:  (252) 737-2879 
 
This consent form may contain words that I do not understand.  I should ask the study doctor or the 
study coordinator to explain any words or information in this consent form that I do not understand. 
 
INTRODUCTION 
 
I have been asked to participate in a research study being conducted by Scott E. Gordon, Ph.D. and his 
associates.  This research is designed to determine the response of several molecules in muscle after 
one resistance exercise (strength training) session, and if this response changes with age.  All of these 
molecules and cells are involved with muscle hypertrophy (growth). 
 
We will study 10 younger (18-45 years) and 20 older inactive adults (46-85 years), at rest and 
during and after a resistance exercise session for the legs.  Inactive is defined as not having 
participated in any regular form of exercise for the past six months (less than 30 minutes per day, 
one day per week).  Studies will take place in the Human Performance Laboratory and Brody 
School of Medicine at East Carolina University. 
 
PLAN AND PROCEDURES 
 
Prior to any testing, I will report to the Human Performance Laboratory Fitness, Instruction, 
Testing, and Training (FITT) Building to first be allowed to read and sign this Informed Consent 
for research as then fill out a medical history questionnaire and 3-day food record. I will be 
allowed to complete this process on the day of my first visit. On this day, I will then undergo 
determination of my height and body weight, and percent body fat.  I will also undergo strength 
testing and familiarization with the resistance exercise test.  One to two weeks later, I will report 
to the East Carolina Heart Institute Room 2379 in a fasted state for the resistance exercise testing 
session, four blood samples from a forearm vein, and 4 biopsies of the thigh muscles. 
 
The following section is an outline of the experimental visits and the procedures to be 
accomplished on each visit.  Note that more detailed descriptions of each procedure 
immediately follow this section.  There will be 2 visits for a total of approximately 5 hours 
of total participation time spread over approximately 2 weeks: 
 
First Visit (Human Performance Lab FITT Building) (1.5 hours): 
1.) Thorough interview in person for informed consent, health history questionnaire, and 3-
day food record. 
2.) Determination of height, weight, and skinfold thickness (fat pinch) for percent body fat. 
3.) Determination of the maximum weight I can lift 10 times (10 repetition maximum, also 
called a 10 RM) for the seated leg extension exercise. 
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4.) Counseling on food choices for those individuals undergoing the high carbohydrate diet, 
and instructions for keeping dietary logs. 
 
Second Visit (East Carolina Heart Institute Room 2379) (7-14 days after initial visit) (3.5 hours): 
1.) I will report to the East Carolina Heart Institute Room 2379, in the morning after an 
overnight fast (not having eaten after midnight the night before). 
2.) Four small blood samples will be obtained during this visit from a forearm vein (before, 
and after exercise). 
3.) Four thigh muscle biopsies (tissue samples) will be performed during this session, two on 
each leg. 
4.) A resistance exercise (strength training leg extension) bout of approximately 15 minutes 
focused on the thigh muscle group will be performed. The bout will consist of 6 sets of 
leg extension exercise.  
 
Detailed Description of the Procedures to be Used During this Study: 
 Body composition screening.  My height and weight will be measured on my first visit.  
My body fat will be estimated by measuring skinfold thicknesses (fat pinch) with a 
skinfold caliper at four sites:  biceps, triceps, back, and waist.  I may feel a slight pinch or 
squeeze from the caliper at the skinfold sites, but no known risks are associated with this 
procedure. 
 Strength testing.  An exercise test to determine my strength levels and familiarize me 
with the resistance exercise protocol will be performed during my first visit (after the 
informed consent).  As part of my familiarization and subject characterization, I will be 
assessed for maximal strength by 10-repetition maximum (10-RM) testing.  This will 
entail determining the maximum amount of weight that I can lift in ten repetitions for the 
leg extension exercise.  This procedure will consist of me initially lifting lighter weights 
and progressing to the heaviest weight that I can lift.  An adequate amount of rest will be 
provided between repetition attempts.  All exercises will be performed on Cybex weight 
machines.  This session will also serve as a familiarization session to make me 
comfortable with the resistance exercise to be performed during the experimental session.  
I will be examined for proper exercise technique during this session and instructions or 
modifications will be provided if necessary.  During this session, my tolerance for the 
heavy resistance exercise protocol will also be assessed. 
 High Carbohydrate Diet.  If I am one of the older subjects that is randomly selected to do 
the high carbohydrate diet, I will be instructed to eat a diet high in carbohydrates for the 3 
days prior to my second visit to the laboratory.  I will be counseled on food choices and 
given food guidelines to assist with dietary choices during the initial visit.  The goal is for 
me to eat approximately 65-70% of my total calories from carbohydrates while 
attempting to decrease my calories from fat accordingly (protein intake will remain 
unaltered).  Some examples of high CHO food choices that are low fat but not low in 
protein are most vegetables, very lean meats, skim (non-fat) milk, etc.  Dr. Kimberly B. 
Heidal, PhD, MHS, RD, LDN, from the ECU Dept. of Nutrition is a team member for 
this study and has provided guidelines and dietary instructions to help accomplish this 
goal.  There is no anticipated risk to me while I undergo this level of carbohydrate 
consumption for 3 days.   
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 Leg resistance exercise workout.  During my second visit to the laboratory, I will perform 
a 15-minute resistance exercise bout focused on the quadriceps (thigh) muscle group.  
The bout will consist of 6 sets of leg extension exercise.  The first 3 sets will be warm-up 
sets performed at 50% (8 repetitions), 70% (6 repetitions), and 90% (4 repetitions) of my 
previously determined 10-RM weight. The fourth through sixth sets will be performed at 
100% of the 10 RM weight and will be performed until I am no longer able to perform 
them on my own (approximately 10 repetitions).  I will rest for 90 seconds between all 
sets 
 Fasting blood draws.  I will not have anything to eat 12 hours prior to my second visit to 
the lab so that blood can be drawn from my forearm vein by a needle. During the second 
visit to the lab, blood will be drawn before, and after the resistance exercise workout 
described above.  Four total blood samples of 5 milliliters each will be obtained during 
this study.  The total amount of blood obtained will be 20 milliliters, which is 
approximately 1/25 of a pint. 
 Muscle Biopsies.  I will undergo four muscle biopsies (tissue samples) to determine the 
levels of several molecules in muscle after one resistance exercise (strength training) 
bout.  These biopsies will be obtained immediately before, immediately after, and 1 and 
2 hours after the resistance exercise bout in visit # 2.  For this procedure, I will have a 
small amount of anesthesia (3 cc of 1% Lidocaine) injected in a ½ inch area under the 
skin of my thigh.  A small (1/4 inch) incision will then be made through the skin, fat and 
fibrous tissue that lies over the muscle.  A biopsy needle (about ½ the width of a pencil) 
will then be inserted ½ to 1 inch into the muscle.  A small piece of muscle (½ the size of 
an eraser on the end of a pencil) will then be clipped out with the biopsy needle.  The 
needle will be withdrawn and the muscle sample immediately preserved by freezing.  Dr. 
Robert Hickner, Ph.D. or Dr. Timothy Gavin, Ph.D. will perform the muscle biopsies.  
These investigators have performed a total of over 500 muscle biopsies. 
 
POTENTIAL RISKS AND DISCOMFORTS  
 
There are certain risks and discomforts that may be associated with this research, including those 
listed below. 
 The general performance of muscular exercise and physical effort can entail the potential 
hazards of injury from overexertion and/or accident.  The possibility of cardiopulmonary 
(heart and lung) overexertion is slight.  It will be minimized by screening, selection, and 
monitoring procedures which are designed to anticipate and exclude the rare individual 
for whom exercise might be harmful.  It is questionable whether it is possible to overexert 
the heart by voluntary physical effort unless there is some underlying disease.  
Nevertheless, there are a number of disorders, some of which can readily escape clinical 
detection, where strenuous exercise may be potentially hazardous or may cause disability.  
Some of these, such as aneurysms (blood vessel ruptures) in the brain, solitary pulmonary 
cysts (small sacs of fluid in the lung), or alveolar blebs (small lung lesions), are rare and 
not readily diagnosed in the absence of symptoms.  For these disorders, a history of 
tolerance to prior physical effort must suffice.  For other, more common conditions such 
as ischemic heart disease (low blood and oxygen flow to the heart), several risk factors 
can be identified through the preliminary medical history and physician screening 
process. 
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 The risks specifically associated with resistance exercise are very low, and this study will 
be planned to avoid injury to the musculoskeletal (muscle and bone) system.  Possible 
risks include the possibility of strains or pulls of the involved muscles, delayed muscle 
soreness 24 to 48 hours after exercise, muscle spasms (cramping), and, in extremely rare 
instances, muscle tears.  Such risks are very low.  Dizziness and fainting may also occur 
infrequently.  I understand that every effort will be made by the researchers to make this 
investigation safe for my participation through proper instruction of the techniques and 
proper warm-up prior to exercise and testing.  Furthermore, risks will be reduced by close 
supervision by experienced personnel to ensure that I utilize proper form. 
 The total amount of blood drawn (1/25 of a pint) is negligible. There is an extremely 
small risk of local hematoma (bruising) or infection associated with insertion of 
venipuncture needles.  In obtaining blood samples from a vein with a needle, the risks to 
me are of local discomfort, syncope (faintness), and hematomas (bruising).  Thrombosis 
(blood clot in the vein), embolism (a blood clot that has come loose and may lodge itself 
in an artery), and infections are potential risks but are of very rare occurrence.  Risks will 
be reduced or eliminated by having investigators who are trained and proficient in 
phlebotomy (puncturing veins with needles) use aseptic techniques.  Furthermore, I will 
be in a seated position while blood is being obtained.  All blood samples will be drawn in 
the laboratory under aseptic conditions with biohazard protection for the investigators 
and myself. 
 Robert Hickner, Ph.D. or Dr. Timothy Gavin, Ph.D. will perform all biopsies, and Dr. 
Walter Pofahl, M.D. will provide medical coverage for biopsies performed in this 
investigation.  There is a small risk of hematoma (bruising) or infection around the 
biopsy site, as well as muscle cramping, mild muscle tenderness and occasional bruising.  
The risk will be minimized by using sterile procedures and applying pressure to the 
biopsy site for 10 minutes, or until bleeding has stopped if longer than 10 minutes.  A 
steri-strip (bandage) will be applied over the incision and will remain in place for at least 
4 days to close the incision during healing.  A pressure wrap will be placed around the 
biopsied thigh and will remain in place for 8 hours following the biopsy.  There is an 
extremely remote risk of allergic reaction to the Lidocaine anesthesia.  This risk will be 
minimized by using subject’s who have had prior exposure to Lidocaine or Novocaine 
anesthesia.  This precaution should eliminate this risk.   
 The procedures and circumstances encompassed by this protocol provide for a high 
degree of safety.  Every attempt will be made by the investigators to minimize any risks 
of this study to me.  This includes familiarization, technique instruction and practice, 
supervision by experienced personnel, screening, and individualized testing and 
monitoring.  The investigators will employ a close interaction with the physician in their 
clinical unit during this study.  My safety will be enhanced in this study with 
individualized supervision during all laboratory visits.  I will be asked to immediately 
alert a member of the research team if I have any injury or health problem.  These factors 
should dramatically contribute to a reduction, if not an elimination, of any potential risks 
associated with this study. 
 There is the potential risk that the results, especially if unfavorable or difficult to 
understand, may lead to my anxiety.  However, I understand that the investigators are 
available to answer any of my questions or concerns regarding such matters, even after 
termination of the study. 
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 To my knowledge, I am not allergic to “caine-type” anesthetics. For example, I have 
not had an allergic reaction to an injection at the dentist’s office. To my knowledge, 
I do not possess any condition which would result in excessive bleeding and I do not 
have known heart disease, i.e., had a heart attack. 
 I am aware that there are unforeseen risks involved with this and all research studies. 
 
POTENTIAL BENEFITS 
 
There are potential benefits to society.  The results of this study will help to determine the response of several 
muscle growth-related molecules and cell types in muscle after one resistance exercise (strength training) session, 
and if this response changes with age.  The benefits of this study far outweigh the risks. 
There are potential benefits to subjects.  I will gain information about my blood sugar (glucose) and insulin levels, which may be indicators of 
health status due to the importance of blood glucose regulation.  These blood glucose and insulin values will be available to me at any time if I 
request them.  Furthermore, if my blood glucose and insulin values fall outside of the normal clinical range, I will be contacted by the 
investigators and advised to consult my personal physician.  I will obtain information about my percent body fat and body mass index (BMI, or 
weight/height squared), which is also an important indicator of risk for metabolic diseases such as diabetes or heart disease.  I will also gain 
information on my muscle fiber type (slow-twitch or fast-twitch), which is important component of athletic ability characteristics. 
 
I will be paid a total of $200.00 compensation upon completion of the entire study. 
 
SUBJECT PRIVACY AND CONFIDENTIALITY OF RECORDS 
 
Only the investigators associated with this study will have access to the data obtained.  The 
identity of the subjects will be protected by numeric coding.  The data will be stored in the office 
of the Principal Investigator, or in a locked storage room. No identifying information will be 
released. 
 
TERMINATION OF PARTICIPATION 
 
My participation in this research study may be terminated without my consent if the investigators 
believe that these procedures will pose unnecessary risk to myself.  I may also be terminated 
from participation if I do not adhere to the study protocol. 
 
COST AND COMPENSATION 
 
I will be paid $50.00 for my time and inconvenience for each muscle biopsy for a maximum of 
$200 for completion of the entire study. There are no costs to me for participation in this study. 
 
The policy of East Carolina University does not provide for 
compensation or medical treatment for subjects because of physical or 
other injury resulting from this research activity.  However, every effort 
will be made to make the facilities of the School of Medicine available 
for treatment in the event of such physical injury. 
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VOLUNTARY PARTICIPATION 
 
I understand that my participation in this study is voluntary.  Refusal to participate will involve no penalty or loss of benefits to which I am 
otherwise entitled.  Furthermore, I may stop participating at any time I choose without penalty, loss of benefits, or without jeopardizing my 
continuing medical care at this institution. 
 
RESEARCH PARTICIPANT AUTHORIZATION TO USE AND DISCLOSE 
PROTECTED HEALTH INFORMATION 
 
The purpose of the information to be gathered for this research study is to better understand the 
response of several molecules in muscle after one resistance exercise (strength training) session, 
and if this response changes with age.  The individuals who will use or disclose my identifiable 
health information for research purposes include Dr. Scott Gordon, Dr. Timothy Gavin, Dr. 
Robert Hickner, Dr. Walter Pofahl, and Mr. Bradley Harper.  Individuals who will receive my 
identifiable health information for research purposes also include Dr. Scott Gordon, Dr. Timothy 
Gavin, Dr. Robert Hickner, Dr. Walter Pofahl, and Mr. Bradley Harper.  The type of information 
accessed for this research study includes 1) general medical history (including family health 
history, medications, nutrition, physical activity levels and body weight history), 2) body 
composition information, blood levels of insulin, glucose, and other compounds related to 
muscle hypertrophy and metabolism, and 3) muscle fiber type percentage as well as growth-
related molecules in my thigh muscle.  The information will be used and disclosed in such a way 
as to protect my identity as much as possible; however, confidentiality cannot be absolutely 
guaranteed.  Someone receiving information collected under this Authorization could potentially 
re-disclose it, and therefore it would no longer be protected under the HIPAA privacy rules 
(federal rules that govern the use and disclosure of my health information).  There is not an 
expiration date for this Authorization. 
 
I may not participate in this study if I do not sign this Authorization form.  I may revoke 
(withdraw) this Authorization by submitting a request in writing to Dr. Scott Gordon.  However, 
the research team will be able to use any and all of the information collected prior to my request 
to withdraw my Authorization.   
 
To authorize the use and disclosure of my health information for this study in the way that has 
been described in this form, I must sign below and date when I signed this form.  A signed copy 
of this Authorization will be given to me for my records. 
 
________________________________________________________________________ 
Participant’s Name (print)                              Signature                                        Date  
 
________________________________________________________________________ 
Authorized Representative Name (print)-----Relationship        Signature             Date  
 
________________________________________________________________________ 
Person Obtaining Authorization                     Signature                                         Date  
 
If I have questions related to the sharing of information, I am advised to call Scott Gordon at 
252-737-2879.  I may also telephone the University and Medical Center Institutional Review 
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Board at 252-744-2914.  In addition, if I have concerns about confidentiality and privacy rights, I 
may phone the Privacy Officer at Pitt County Memorial Hospital at 252-847-6545 or at East 
Carolina University at 252-744-2030. 
 
PERSONS TO CONTACT WITH QUESTIONS 
 
The investigators will be available to answer any questions concerning this research, now or in 
the future.  I may contact the primary investigators Scott E. Gordon, Ph.D. at 252-737-2879 
(weekdays) or 252-321-7655 (nights and weekends).  Also, if questions arise about my rights as 
a research subject, I may contact the Chairman of the University and Medical Center Institutional 
Review Board at phone number 252-744-2914 (weekdays).  
 
CONSENT TO PARTICIPATE 
 
I certify that I have read all of the above, asked questions and received answers concerning areas 
I did not understand, and have received satisfactory answers to these questions. I willingly give 
my consent for participation in this research study.  (A copy of this consent form will be given to 
the person signing as the subject or as the subject’s authorized representative.) 
 
_____________________________________________________________ 
Participant’s Name (Print) 
 
_____________________________________________________________ 
Signature of Participant    Date  Time 
 
WITNESS:  I confirm that the contents of this consent document were orally presented, the 
participant or guardian indicates all questions have been answered to his or her satisfaction, and 
the participant or guardian has signed the document.  
 
 
_____________________________________________________________ 
Witness’s Name (Print) 
 
_____________________________________________________________ 
Signature of Witness      Date   
 
 
PERSON ADMINISTERING CONSENT:  I have conducted the consent process and orally 
reviewed the contents of the consent document. I believe the participant understands the 
research. 
 
_____________________________________________________________ 
Person Obtaining Consent (Print) 
 
_____________________________________________________________ 
Signature of Person Obtaining Consent        Date 
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_____________________________________________________________ 
Principal Investigator’s Name (Print) 
 
_____________________________________________________________ 
Signature of Principal Investigator          Date 
 
 
90 
 
FUTURE TESTING OF BLOOD/MUSCLE SAMPLES 
 
Upon termination of this study, the blood and muscle samples collected for this study will be 
stored for up to 7 years to research scientific questions specifically related to age-related changes 
in molecules regulating muscle mass in response to resistance exercise.  I understand that I have 
the right to decline consent for this storage beyond termination of the present study, and that this 
declination of consent would not exclude me from participation in the present study.  I will 
continue to be the owner of the samples and retain the right to have the sample material 
destroyed at any time during this study by contacting the study principal investigator Scott 
Gordon, Ph.D. at 252-737-2879.  During this study, the samples will be stored with number 
identifiers only; however, the number identifier will be linked to a specific name and will be 
kept on file in the possession of the principal investigator.  The linked file will be stored 
password protected on the Principal Investigator’s computer with CD backup.  No other 
individuals will have access to these identifying materials unless the principal investigator is 
required by law to provide such identifying information.  Data will not be publicly available and 
participants will not be identified or linked to the samples in publication.  If a commercial 
product is developed from this research project, I will not profit financially from such a product.  
Furthermore, there are no plans for me to profit financially from such a product.   
 
 
CONSENT TO PARTICIPATE IN FUTURE TESTING OF 
BLOOD/MUSCLE SAMPLES  
 
I certify that I have read all of the above, asked questions and received answers concerning areas 
I did not understand, and have received satisfactory answers to these questions.  I willingly give 
my consent for participation in this research study.  (A copy of this consent form will be given to 
the person signing as the subject or as the subject’s authorized representative.) 
 
_____________________________________________________________ 
Participant’s Name (Print) 
 
_____________________________________________________________ 
Signature of Participant    Date  Time 
 
WITNESS:  I confirm that the contents of this consent document were orally presented, the 
participant or guardian indicates all questions have been answered to his or her satisfaction, and 
the participant or guardian has signed the document.  
 
 
_____________________________________________________________ 
Witness’s Name (Print) 
 
_____________________________________________________________ 
Signature of Witness      Date   
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PERSON ADMINISTERING CONSENT:  I have conducted the consent process and orally 
reviewed the contents of the consent document. I believe the participant understands the 
research. 
 
_____________________________________________________________ 
Person Obtaining Consent (Print) 
 
_____________________________________________________________ 
Signature of Person Obtaining Consent        Date 
 
 
 
_____________________________________________________________ 
Principal Investigator’s Name (Print) 
 
_____________________________________________________________ 
Signature of Principal Investigator          Date 
 
 
 
 
 
APPENDIX C:  PERSONAL HISTORY FORM 
PERSONAL HISTORY FORM                                                           (version 2-17-09) 
 
Technician _______________________    Contract ________________  ID _________ 
 
   PLEASE PRINT AND FILL OUT  COMPLETELY  
 
1. Name: ______________________________  Date: ___________________ 
 Phone#: (home) ____________________ (work) ________________________ 
 Address: __________________________________________________________ 
 City: _______________________ State ___________  Zip ______________ 
 e-mail address (if available):___________________________________________ 
2. Employer: ________________________________________________________ 
 Occupation: _______________________________________________________ 
 
3. Date of Birth: ________________ Sex: _______   Age: _______ Race:  _______ 
 
4.  General Medical History                    Circle one  
Any medical  complaints presently?    (if yes, explain) ....                                     yes    no 
____________________________________________________________ 
____________________________________________________________ 
____________________________________________________________ 
 
Any major illnesses in the past?  (if yes, explain) ..... (date) ______         yes   no 
____________________________________________________________ 
____________________________________________________________ 
____________________________________________________________ 
 
Any hospitalization or surgery?  (if yes, explain)  ......    (date)  _________          yes    no 
____________________________________________________________ 
____________________________________________________________ 
____________________________________________________________ 
 
Have you ever had an EKG (electrocardiogram) ? ......    (date)  _________         yes    no 
 
 
Are you diabetic?  ....If yes, at what age did you develop diabetes: _________    yes    no 
 
Are you currently taking any medications? .............................          yes    no 
 
Medication  Dosage Reason  Times taken per day 
______________________________________________________________________ 
______________________________________________________________________ 
 
5.  Family History 
  Age if    Age of   Cause of 
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  alive    death   death 
Father  ______   ________ ____________________ 
Mother ______   ________ ____________________ 
 
 
 
Do you have a family history of: (Blood relatives only: give age of occurrence if applicable) 
       Relationship   Age of 
           occurrence 
--High blood pressure ...... yes    no   ______________________________ 
--Heart attack.....................yes    no   ______________________________ 
--By-pass surgery...............yes    no   ______________________________ 
--Stroke..............................yes    no   ______________________________ 
--Diabetes...........................yes    no               ______________________________ 
--Gout.................................yes    no   ______________________________ 
--Obesity.............................yes    no              ______________________________ 
 
6.  Tobacco History  (check one) 
_____   None       Cigarette history 
_____   Quit months/years ago    _____   1-10 daily 
_____   Cigarette      _____    11-20 “ 
_____   Snuff       _____    21-30 “ 
_____   Chewing tobacco      _____    31-40   “ 
_____   Pipe       _____    more than 40 
Total years of tobacco use? _______     
 
Snuff history       Chewing history  
______   < 0.5 cans daily     _____   < 0.5 pouches daily 
______   0.5-2.5 cans  “     _____   0.5-2.5 pouches  “ 
______   > 2.5 cans     “      _____   > 2.5 pouches     “ 
 
7. Weight History  
What do you consider a good weight for you? ________ Weight at age 21? _________ 
Weight since age 21? ________    Weight one year ago? ______ 
Weight now? ________ 
 
8. Cardio-Respiratory History 
 
Any heart disease now?..........................................................................................    yes  no 
 
Any heart disease in the past?................................................................................  yes  no 
 
Heart murmur?........................................................................................................ yes  no 
 
Occasional chest pains?........................................................................................    yes  no 
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Chest pains on exertion?.........................................................................................  yes  no 
 
Fainting?.................................................................................................................  yes  no 
 
Daily coughing?.....................................................................................................  yes  no 
 
Cough that produces sputum?............................................................................... . yes  no 
 
High blood pressure?.............................................................................................  yes  no 
 
Shortness of breath -- 
 at rest.......................................................................................................    yes  no 
 lying down..............................................................................................    yes  no 
 sleeping at night.....................................................................................    yes  no 
 after 2 flights of stairs...........................................................................     yes  no 
 
9.  Muscular  History 
 
Any muscle injuries or illnesses now?................................................................    yes  no 
 
Any muscle injuries in the past?.........................................................................    yes  no 
 
Muscle pain at rest?............................................................................................    yes  no 
 
Muscle pain on exertion?...................................................................................    yes  no 
 
10.  Bone-Joint History 
 
Any bone or joint (including spinal) injuries or illnesses now?........................    yes  no 
 
Any bone or joint (including spinal) injuries or illnesses in the past?..............    yes  no 
 
Ever had painful joints?....................................................................................   yes  no 
 
Ever had swollen joints?..................................................................................    yes  no 
 
Flat feet?...........................................................................................................   yes  no 
 
11.  Menstrual History (Women only) 
 
Are you post-menopausal (e.g., not had menstrual flow for at least one year)? ... yes  no 
 
Have you had a hysterectomy? .............................................................................    yes  no 
 
If you have had a hysterectomy, were the ovaries removed? ………………......    yes  no 
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If pre-menopausal:  On what date did your last period start (beginning of flow)? ____________ 
 Are your periods regular? .....................................................    yes  no 
Approximately how many days apart are your periods?      _____________ 
Are you on any hormonal supplements, such as a birth control pill or 
estrogen replacement therapy? .............................................................................    yes  no 
 If so, what? ________________________________ 
 
12.  Nutritional Survey 
How many times do you usually eat per day?                                                   ________ 
 
What time of day do you eat your largest meal?                                               ________ 
 
How many times per week do you usually eat...     
 ____ Hamburger ____ Sausage  ____ Bacon 
 ____ Beef  ____ Pork  ____ Cheese 
 ____ Shellfish (shrimp, oysters, scallops, clams, etc.) 
 ____ Fish  ____Poultry  ____ Fried Foods 
 ____ Breads  ____ Cereals  ____ Vegetables 
 ____ Eggs  ____ Desserts  ____ Ice Cream 
 ____ Other 
 
How many servings per week do you usually consume? 
____ Whole milk   ____ Coffee 
____ Low-fat milk (2% milk fat) ____ Tea 
____ Skim milk (non-fat)  ____ Soft drinks 
____ Buttermilk   ____ Other 
 
 
 
 
 
 
13.  Physical Activity Survey 
a.  Compared to a year ago, how much regular physical activity do you currently get?  (Check 
One) 
 ____  much less  ____  somewhat less  ____  about the same 
 ____  somewhat more  ____  much more 
 
b.  For the last three months, have you been exercising on a regular basis?............  yes  no 
 
c.  What type of exercise or physical activity do you currently do or have done regularly in the 
past?   
     (For example:  walking, swimming, weight lifting, gardening, etc.)  
______________________________________________________________________________
______________________________________________________________________________
____________________________________________________________ 
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d.  On the average, how many days per week do you exercise? _______ 
 
e.  How long do you exercise each time?  For how many minutes?  __________________ 
 
f.  How hard do you exercise on a scale from 1 to 5:  with 1 being easy and 5 being very hard? 
 ____ 1  ____ 2  ____ 3  ____ 4  ____ 5 
 
g.  Do you ever check your heart rate (pulse) to determine how hard you are exercising? 
 ____ yes ____ no 
 
h.  What aerobic activity or activities would you prefer in a regular exercise program for 
yourself? 
____ Walking and/or running  ____ Tennis   ____ Bicycling 
____ Racquetball   ____ Swimming  ____ Basketball 
____ Aerobic dance   ____ Stationary cycling ____ Soccer  
____ Stair climbing   ____ Rowing   ___________Other 
  
14.  Alcohol History 
Do you ever drink alcoholic beverages?    Yes ____  No ____  
If yes, what is your approximate intake of beverages per week?   
Beer _____ Wine _____ Mixed Drinks _____   
 
15.  Sleeping Habits 
Do you ever experience insomnia (trouble sleeping)? Yes ____ No ____ 
If yes, approximately how often?___________________________________________________ 
How many hours of sleep do you usually average per night?_____________________________ 
 
16.  Education 
Please indicate the highest level of education completed. 
____ Grade School  ____ Junior High  ____ High School  
____ College   ____ Graduate  ____ Postgraduate 
Please indicate degree earned (i.e. B.A., M.S., Ph.D.)_____________________________   
 
17.  Motivation or reason for participating in the testing program? 
____ General health and fitness evaluation 
____ Medical evaluation prior to starting and exercise program 
____ Baseline for weight loss 
____ Required by supervisors or employers 
____ Other ______________________________________________________ 
 
18.  Family Physician 
Name:  _________________________________________________________ 
Address:________________________________________________________ 
Phone:  _________________________ 
Should it be necessary, may we send a copy of your results to your physician? 
 
 
97 
 
 
19.  Insurance  I, _____________________understand that this evaluation is not reimbursable 
under Medicare and the cost of the evaluation must be paid by me. 
 
Signature:  ________________________________ 
Date:  ___________________________________ 
 
 
 
 
APPENDIX D:  DIETARY LOG FOR A TYPICAL DAY 
Date _________________    Subject ID # _____________ 
 
Dietary Log for a Typical Day 
 
Meal Time of 
day 
Serving 
Size 
Food Item Prepared by: 
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
 
Please list all other vitamins, minerals, and supplements that you normally take in a day: 
___________________________________________________________________ 
_______________________________________________________________________ 
 
 
 
 
 
APPENDIX E:  EXPERIMENTAL SESSION INSTRUCTIONS 
Age-related Changes in Skeletal Muscle Signaling after Acute Heavy 
Resistance Exercise 
Principal Investigator: Scott E. Gordon, Ph.D. 
Telephone #:  (252) 737-2879 
Sub Investigators: Jen Macesich & Hope Tharrington 
Telephone #:  (919) 606-2853 & (252) 883-2001 
 
EXPERIMENTAL SESSION INSTRUCTIONS 
 
Human Performance Laboratory 
 
 
 
For three full days prior to session (Start Date: _______________): 
 
1. Follow the high carbohydrate diet instructions. 
2. Completely fill out diet log. 
3. Do not drink alcohol 
4. If you consume caffeine, do so only in moderation. 
5. Drink at least 64 oz. of water per day (i.e., eight 8-oz. glasses). 
 
On day of experimental session (Date _______________): 
 
1. Drink 16 oz. of water before reporting to the laboratory. 
2. **Do not eat or drink anything but water for the 12 hours prior to reporting to the laboratory!! 
3. **Do not exercise before the experimental session!! 
4. Report to the Brody School of Medicine, room 3S08 at _______________. 
5. Wear exercise clothes, specifically shorts and athletic shoes, to the experimental session. 
 
For the duration of the experiments: 
  
1. Do not engage in exercise. 
2. Do not donate blood or plasma. 
3. If you begin taking new medications, please notify Jen Macesich or Hope Tharrington. 
 
 
 
 
 
APPENDIX F:  DIETARY INTERVENTION GUIDELINES 
 
The goal for this 3-day diet is to lower fat intake, increase carbohydrate intake, and keep 
protein intake approximately the same as your normal intake. 
 
Total calories should also remain approximately the same as your normal intake. 
 
In the 3 days before your next visit, please try to make the following food choices (also see 
attached Food Guide Pyramid): 
 Increase your choices from the Bread/Cereal/Rice/Pasta Group. 
 Increase your choices from the Fruit Group. 
 Increase your choices from the Vegetable Group. 
 Reduce (or choose non-fat or low fat) choices from the Milk/Yogurt/Cheese Group. 
-Choose skim (non-fat) milk or 1% fat milk instead of 2% or whole milk. 
-Choose cheese or yogurt products that are labeled as non-fat or low fat. 
 Choose only lean meats from the Meat/Poultry/Fish/Beans/Eggs/Nuts Group. 
-Choose chicken, turkey or fish instead of pork or beef (red meat, hamburger, 
etc.). 
-For chicken and turkey:  Choose white meat (breast meat) instead of dark 
meat (legs and wings). 
-For chicken and turkey:  Remove all skin. 
-Avoid processed or fried meats such as bacon, sausage, hot dogs, salami, 
kielbasa, and pepperoni. 
-Avoid creamy or oily sauces/toppings on all meats. 
-Avoid nuts or nut products (i.e., peanut butter). 
-Beans or legumes are a good choice as a side dish when available. 
 Reduce your choices from the Fats/Oils/Sweets Group. 
 
Also, please try to: 
 Avoid fried foods in general. 
 Substitute fruit juice instead of milk (unless it is skim milk or 1% fat milk). 
 Avoid creamy or oily dressings on salads and avoid creamy or oily sauces on pasta 
(unless they are labeled as non-fat or low-fat). 
 Avoid a lot of butter, margarine, or sour cream on baked potatoes or other foods on 
which you place toppings. 
 Substitute fruit spreads (jams, jellies, applesauce, etc.) instead of butter, margarine, 
or cream cheese. 
 Substitute Pam or other light cooking spray instead of oils when cooking. 
 Be careful:  Many “sweet” items (such as cakes, ice cream, and candy bars) are also 
high in fat. 
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